Infectious Disease and Microbiology – Rhodotorula Species

Overview

Rhodotorula species are pigmented yeasts that are widely distributed in the environment. They are frequently recovered from clinical specimens as colonizers or contaminants, but they can act as true opportunistic pathogens, particularly in immunocompromised patients and those with indwelling central venous catheters.

The most characteristic invasive syndrome is catheter-associated fungemia. Other important infections include peritoneal dialysis-associated peritonitis and endocarditis.

Classification

Genus: Rhodotorula

Important species include:

• Rhodotorula glutinis

• Rhodotorula rubra

The organism historically called R. rubra is commonly referred to in modern taxonomy as:

Rhodotorula mucilaginosa

and is an important species associated with human infection.

Microbiologic Characteristics

Rhodotorula species are:

• Yeasts

• Rapid growing

• Capable of producing mature colonies within approximately 4 days

• Characterized by round or oval budding yeast cells

• Associated with few or rudimentary pseudohyphae

A particularly useful laboratory characteristic is their distinctive:

Pink, coral, orange, or reddish colony pigmentation

High-Yield Microbiology Pattern

Yeast

• ●

Pink/coral-red colonies

• ●

Central venous catheter

• ●

Fungemia

→ Think Rhodotorula

Pigmentation

One of the most characteristic features of Rhodotorula is the production of:

Carotenoid pigments

These pigments give colonies their characteristic:

Pink to coral-red/orange appearance

This feature can help distinguish Rhodotorula from many other clinically important yeasts.

Microscopic Appearance

In culture, microscopy demonstrates:

Round or oval budding yeast cells

with:

Few or rudimentary pseudohyphae

Extensive pseudohyphal formation is generally not a dominant feature.

High-Yield Laboratory Pattern

Budding yeast

• ●

Minimal pseudohyphae

• ●

Rapid-growing pink/coral colonies

→ Rhodotorula

Incubation Period

The incubation period is:

Unknown

Because Rhodotorula primarily causes opportunistic infection rather than a predictable acute transmissible syndrome, there is no characteristic incubation period.

Epidemiology

Rhodotorula species have a:

Worldwide distribution

They are widely present in environmental and human-associated settings.

They may be recovered from:

• Soil

• Water

• Air

• Moist environmental surfaces

• Food

• Human skin and mucosal surfaces

Contaminant vs. Pathogen

A major clinical issue is determining whether recovery of Rhodotorula represents:

CONTAMINATION/COLONIZATION

or

TRUE INVASIVE INFECTION

Because these yeasts are common environmental organisms, their isolation does not always indicate disease.

When to Suspect True Infection

True infection becomes more likely when Rhodotorula is recovered in a patient with:

• Central venous catheter

• Significant immunosuppression

• Repeated positive blood cultures

• Compatible signs of sepsis

• Peritoneal dialysis catheter

• Prosthetic material

• Isolation from another normally sterile site

High-Yield Clinical Principle

Rhodotorula in a superficial/nonsterile specimen

→ May represent colonization or contamination

Repeated Rhodotorula-positive blood cultures + central venous catheter

→ Strongly consider true fungemia

Immunocompromised Hosts

Rhodotorula becomes particularly important as an opportunistic pathogen in patients with impaired host defenses.

Risk factors may include:

• Malignancy

• Neutropenia

• Immunosuppressive therapy

• Organ transplantation

• Prolonged hospitalization

• Broad-spectrum antimicrobial exposure

• Invasive medical devices

However, one of the strongest recurring clinical associations is:

Central venous catheterization

Fungemia

The most important invasive infection is:

FUNGEMIA

This is particularly associated with:

Central venous catheters

The catheter can provide a surface for microbial adherence and persistent bloodstream infection.

Catheter-Associated Fungemia

A typical sequence is:

Skin/environmental yeast

↓

Catheter colonization

↓

Adherence and biofilm formation

↓

Persistent bloodstream infection

↓

Rhodotorula fungemia

Classic Clinical Pattern

Immunocompromised patient

• ●

Central venous catheter

• ●

Fungemia

• ●

Pink/coral-red yeast colonies

→ Think Rhodotorula

Peritoneal Dialysis-Associated Peritonitis

Rhodotorula may cause:

Peritonitis

in patients undergoing:

Peritoneal dialysis

The dialysis catheter can act as both:

Portal of entry + persistent infectious focus

This is another example of the organism’s strong association with:

Indwelling medical devices

High-Yield Dialysis Pattern

Peritoneal dialysis

• ●

Peritonitis

• ●

Pigmented yeast

→ Consider Rhodotorula

Endocarditis

Rarely, Rhodotorula can cause:

Endocarditis

This is a serious invasive manifestation.

Underlying prosthetic material, intravascular devices, or immunocompromise may increase the likelihood that an unusual yeast isolate represents a genuine pathogen.

Diagnosis

Diagnosis is based primarily on:

Culture

and may be supported by:

Histopathology

Culture

Culture typically demonstrates:

Rapidly growing yeast colonies

with characteristic:

Pink, coral, orange, or red pigmentation

Mature colonies may develop within approximately:

4 days

according to the source.

Histopathology

Histopathologic examination may demonstrate:

Budding yeast forms

within affected tissue.

However, species identification generally depends on microbiologic methods rather than histologic appearance alone.

Blood Cultures

For suspected fungemia:

Blood cultures

are particularly important.

Repeated isolation from blood in a patient with an indwelling central venous catheter strongly supports:

True catheter-associated infection

rather than simple contamination.

Rhodotorula vs. Candida

Both organisms are:

Yeasts

and both may cause:

Catheter-associated bloodstream infection

However:

Rhodotorula

→ Pink/coral-red pigmentation

→ Usually limited pseudohyphal development

→ Often environmental/colonizing organism

→ Important opportunistic catheter-associated pathogen

Candida

→ Usually cream-colored colonies

→ Several species form pseudohyphae

→ Much more common cause of invasive yeast infection

Rhodotorula vs. Cryptococcus

Both can produce relatively round budding yeast cells.

Rhodotorula

→ Pigmented pink/coral colonies

→ Central venous catheter-associated fungemia is characteristic

Cryptococcus

→ Prominent polysaccharide capsule

→ Classically associated with pulmonary and CNS infection

→ Cryptococcal antigen is diagnostically important

Treatment

The source recommends:

Amphotericin B

with or without:

Flucytosine

for invasive Rhodotorula infection.

Amphotericin B

For serious invasive disease, amphotericin B has historically been an important therapeutic agent.

Because Rhodotorula infections are uncommon, management should also consider:

Species identification + antifungal susceptibility + infection site + host factors

Flucytosine

The source lists:

Flucytosine

as a possible additional agent in combination with amphotericin B.

Thus, the source treatment pattern is:

Amphotericin B ± flucytosine

Important Azole Resistance

An important therapeutic characteristic is that Rhodotorula species may demonstrate poor susceptibility or intrinsic resistance to several commonly used antifungal agents, particularly:

Fluconazole

Therefore, treatment should not simply be extrapolated from standard management of Candida infections.

High-Yield Treatment Pattern

Rhodotorula fungemia

→ Amphotericin B-based therapy

• ●

Remove the infected catheter when appropriate

→ Avoid assuming fluconazole will provide reliable therapy

Echinocandin Activity

Another important distinction from Candida is that Rhodotorula generally has:

Poor susceptibility to echinocandins

Therefore, drugs commonly used empirically for candidemia may not necessarily provide appropriate definitive therapy for Rhodotorula.

Source Control

Because many cases of fungemia are associated with:

Central venous catheters

management frequently requires:

Catheter removal

when feasible.

Similarly, peritoneal dialysis-associated infection may require evaluation of the:

Peritoneal dialysis catheter

for removal or replacement.

Why Catheter Removal Matters

The organism can persist on foreign surfaces through:

Adherence and biofilm-associated growth

Therefore:

Antifungal therapy alone

may fail if an infected device remains in place.

High-Yield Management Principle

Pigmented yeast + catheter-associated fungemia

→ Identify organism

→ Perform susceptibility testing when appropriate

→ Give active antifungal therapy

→ Remove infected catheter/source when feasible

Prevention

There is no vaccine against Rhodotorula.

General preventive measures include:

• Appropriate central-line insertion technique

• Strict catheter hygiene

• Removal of unnecessary central venous catheters

• Appropriate peritoneal dialysis catheter care

• Standard infection-control practices

High-Yield Clinical Pattern

Immunocompromised host

• ●

Central venous catheter

• ●

Repeated yeast-positive blood cultures

• ●

Pink/coral-red colonies

→ Think RHODOTORULA

Exam Essentials

Genus: Rhodotorula

Important species: R. glutinis and R. mucilaginosa (historically R. rubra)

Organism: Yeast

Growth: Relatively rapid; source describes mature growth in approximately 4 days

Microscopy: Round/oval budding cells with few rudimentary pseudohyphae

Classic colony color: Pink, coral, orange, or red

Pigment: Carotenoid

Distribution: Worldwide

Clinical significance: Frequently colonizer/contaminant, but can be an opportunistic pathogen

Major host: Immunocompromised patient

Major risk factor: Central venous catheter

Classic infection: Catheter-associated fungemia

Other infections: Peritoneal dialysis-associated peritonitis and endocarditis

Diagnosis: Culture ± histopathology

Source treatment: Amphotericin B ± flucytosine

Important susceptibility clue: Fluconazole is generally unreliable

Echinocandins: Generally have poor activity

Management principle: Antifungal therapy + source control, particularly catheter removal when appropriate

Key clinical pearl: Rhodotorula is a distinctive pink-to-coral pigmented yeast that is often dismissed as a contaminant but can cause genuine invasive disease, especially central venous catheter-associated fungemia in immunocompromised patients. Repeated bloodstream isolation should be taken seriously; amphotericin B-based treatment and catheter source control are important, while fluconazole and echinocandins generally should not be assumed to provide reliable activity.

Classification Genus: Rhodotorula Important species include: • Rhodotorula glutinis

• Rhodotorula rubra The organism historically called R. rubra is commonly referred to in modern taxonomy as: Rhodotorula mucilaginosa and is an important species associated with human infection.

Microbiologic Characteristics Rhodotorula species are: • Yeasts

• Rapid growing

• Capable of producing mature colonies within approximately 4 days

• Characterized by round or oval budding yeast cells

• Associated with few or rudimentary pseudohyphae A particularly useful laboratory characteristic is their distinctive: Pink, coral, orange, or reddish colony pigmentation

High-Yield Microbiology Pattern Yeast  ●  Pink/coral-red colonies  ●  Central venous catheter  ●  Fungemia → Think Rhodotorula

Pigmentation One of the most characteristic features of Rhodotorula is the production of: Carotenoid pigments These pigments give colonies their characteristic: Pink to coral-red/orange appearance This feature can help distinguish Rhodotorula from many other clinically important yeasts.

Microscopic Appearance In culture, microscopy demonstrates: Round or oval budding yeast cells with: Few or rudimentary pseudohyphae Extensive pseudohyphal formation is generally not a dominant feature.

High-Yield Laboratory Pattern Budding yeast  ●  Minimal pseudohyphae  ●  Rapid-growing pink/coral colonies → Rhodotorula

Incubation Period The incubation period is: Unknown Because Rhodotorula primarily causes opportunistic infection rather than a predictable acute transmissible syndrome, there is no characteristic incubation period.

Epidemiology Rhodotorula species have a: Worldwide distribution They are widely present in environmental and human-associated settings. They may be recovered from: • Soil

• Water

• Air

• Moist environmental surfaces

• Food

• Human skin and mucosal surfaces

Contaminant vs. Pathogen A major clinical issue is determining whether recovery of Rhodotorula represents: CONTAMINATION/COLONIZATION or TRUE INVASIVE INFECTION Because these yeasts are common environmental organisms, their isolation does not always indicate disease.

When to Suspect True Infection True infection becomes more likely when Rhodotorula is recovered in a patient with: • Central venous catheter

• Significant immunosuppression

• Repeated positive blood cultures

• Compatible signs of sepsis

• Peritoneal dialysis catheter

• Prosthetic material

• Isolation from another normally sterile site

High-Yield Clinical Principle Rhodotorula in a superficial/nonsterile specimen → May represent colonization or contamination Repeated Rhodotorula-positive blood cultures + central venous catheter → Strongly consider true fungemia

Immunocompromised Hosts Rhodotorula becomes particularly important as an opportunistic pathogen in patients with impaired host defenses. Risk factors may include: • Malignancy

• Neutropenia

• Immunosuppressive therapy

• Organ transplantation

• Prolonged hospitalization

• Broad-spectrum antimicrobial exposure

• Invasive medical devices However, one of the strongest recurring clinical associations is: Central venous catheterization

Fungemia The most important invasive infection is: FUNGEMIA This is particularly associated with: Central venous catheters The catheter can provide a surface for microbial adherence and persistent bloodstream infection.

Catheter-Associated Fungemia A typical sequence is: Skin/environmental yeast ↓ Catheter colonization ↓ Adherence and biofilm formation ↓ Persistent bloodstream infection ↓ Rhodotorula fungemia

Classic Clinical Pattern Immunocompromised patient  ●  Central venous catheter  ●  Fungemia  ●  Pink/coral-red yeast colonies → Think Rhodotorula

Peritoneal Dialysis-Associated Peritonitis Rhodotorula may cause: Peritonitis in patients undergoing: Peritoneal dialysis The dialysis catheter can act as both: Portal of entry + persistent infectious focus This is another example of the organism’s strong association with: Indwelling medical devices

High-Yield Dialysis Pattern Peritoneal dialysis  ●  Peritonitis  ●  Pigmented yeast → Consider Rhodotorula

Endocarditis Rarely, Rhodotorula can cause: Endocarditis This is a serious invasive manifestation. Underlying prosthetic material, intravascular devices, or immunocompromise may increase the likelihood that an unusual yeast isolate represents a genuine pathogen.

Diagnosis Diagnosis is based primarily on: Culture and may be supported by: Histopathology

Culture Culture typically demonstrates: Rapidly growing yeast colonies with characteristic: Pink, coral, orange, or red pigmentation Mature colonies may develop within approximately: 4 days according to the source.

Histopathology Histopathologic examination may demonstrate: Budding yeast forms within affected tissue. However, species identification generally depends on microbiologic methods rather than histologic appearance alone.

Blood Cultures For suspected fungemia: Blood cultures are particularly important. Repeated isolation from blood in a patient with an indwelling central venous catheter strongly supports: True catheter-associated infection rather than simple contamination.

Rhodotorula vs. Candida Both organisms are: Yeasts and both may cause: Catheter-associated bloodstream infection However: Rhodotorula → Pink/coral-red pigmentation

→ Usually limited pseudohyphal development

→ Often environmental/colonizing organism

→ Important opportunistic catheter-associated pathogen Candida → Usually cream-colored colonies

→ Several species form pseudohyphae

→ Much more common cause of invasive yeast infection

Rhodotorula vs. Cryptococcus Both can produce relatively round budding yeast cells. Rhodotorula → Pigmented pink/coral colonies

→ Central venous catheter-associated fungemia is characteristic Cryptococcus → Prominent polysaccharide capsule

→ Classically associated with pulmonary and CNS infection

→ Cryptococcal antigen is diagnostically important

Treatment The source recommends: Amphotericin B with or without: Flucytosine for invasive Rhodotorula infection.

Amphotericin B For serious invasive disease, amphotericin B has historically been an important therapeutic agent. Because Rhodotorula infections are uncommon, management should also consider: Species identification + antifungal susceptibility + infection site + host factors

Flucytosine The source lists: Flucytosine as a possible additional agent in combination with amphotericin B. Thus, the source treatment pattern is: Amphotericin B ± flucytosine

Important Azole Resistance An important therapeutic characteristic is that Rhodotorula species may demonstrate poor susceptibility or intrinsic resistance to several commonly used antifungal agents, particularly: Fluconazole Therefore, treatment should not simply be extrapolated from standard management of Candida infections.

High-Yield Treatment Pattern Rhodotorula fungemia → Amphotericin B-based therapy  ●  Remove the infected catheter when appropriate → Avoid assuming fluconazole will provide reliable therapy

Echinocandin Activity Another important distinction from Candida is that Rhodotorula generally has: Poor susceptibility to echinocandins Therefore, drugs commonly used empirically for candidemia may not necessarily provide appropriate definitive therapy for Rhodotorula.

Source Control Because many cases of fungemia are associated with: Central venous catheters management frequently requires: Catheter removal when feasible. Similarly, peritoneal dialysis-associated infection may require evaluation of the: Peritoneal dialysis catheter for removal or replacement.

Why Catheter Removal Matters The organism can persist on foreign surfaces through: Adherence and biofilm-associated growth Therefore: Antifungal therapy alone may fail if an infected device remains in place.

High-Yield Management Principle Pigmented yeast + catheter-associated fungemia → Identify organism → Perform susceptibility testing when appropriate → Give active antifungal therapy → Remove infected catheter/source when feasible

Prevention There is no vaccine against Rhodotorula. General preventive measures include: • Appropriate central-line insertion technique

• Strict catheter hygiene

• Removal of unnecessary central venous catheters

• Appropriate peritoneal dialysis catheter care

• Standard infection-control practices

High-Yield Clinical Pattern Immunocompromised host  ●  Central venous catheter  ●  Repeated yeast-positive blood cultures  ●  Pink/coral-red colonies → Think RHODOTORULA

Exam Essentials Genus: Rhodotorula

Important species: R. glutinis and R. mucilaginosa (historically R. rubra)

Organism: Yeast

Growth: Relatively rapid; source describes mature growth in approximately 4 days

Microscopy: Round/oval budding cells with few rudimentary pseudohyphae

Classic colony color: Pink, coral, orange, or red

Pigment: Carotenoid

Distribution: Worldwide

Clinical significance: Frequently colonizer/contaminant, but can be an opportunistic pathogen

Major host: Immunocompromised patient

Major risk factor: Central venous catheter

Classic infection: Catheter-associated fungemia

Other infections: Peritoneal dialysis-associated peritonitis and endocarditis

Diagnosis: Culture ± histopathology

Source treatment: Amphotericin B ± flucytosine

Important susceptibility clue: Fluconazole is generally unreliable

Echinocandins: Generally have poor activity

Management principle: Antifungal therapy + source control, particularly catheter removal when appropriate

Key clinical pearl: Rhodotorula is a distinctive pink-to-coral pigmented yeast that is often dismissed as a contaminant but can cause genuine invasive disease, especially central venous catheter-associated fungemia in immunocompromised patients. Repeated bloodstream isolation should be taken seriously; amphotericin B-based treatment and catheter source control are important, while fluconazole and echinocandins generally should not be assumed to provide reliable activity.

Infectious Disease and Microbiology – Rhodococcus Species

Overview

Rhodococcus species are aerobic Gram-positive coccobacilli that may demonstrate weak or variable acid-fast staining. They are environmental organisms capable of surviving within host cells, particularly macrophages.

The most clinically important species is Rhodococcus equi, an opportunistic pathogen best known for causing pulmonary infection in patients with impaired cell-mediated immunity. Pneumonia may be acute, subacute, or chronic and frequently produces nodules, consolidation, or cavitary lesions, creating an important differential diagnosis with tuberculosis and nocardiosis.

Classification

Genus: Rhodococcus

Important species include:

• R. aurantiacus

• R. bronchialis

• R. equi — most clinically important

• R. erythropolis

• R. luteus

• R. rhodochrous

• R. rubropertinctus

Microbiologic Characteristics

Rhodococcus organisms are typically:

• Aerobic

• Gram-positive

• Coccobacillary or pleomorphic

• Non-spore-forming

• Capable of intracellular survival

• Sometimes weakly or partially acid-fast

Their morphology may vary during growth, which can sometimes complicate laboratory recognition.

High-Yield Microbiology Pattern

Aerobic Gram-positive coccobacillus

• ●

Weakly acid-fast

• ●

Intracellular pathogen

• ●

Cavitary pneumonia in an immunocompromised patient

→ Think Rhodococcus equi

Environmental Reservoir

R. equi is primarily an:

Environmental organism

It is particularly associated with:

• Soil

• Dust

• Animal environments

• Horse farms

A particularly important reservoir is:

Horses and horse-associated soil

The organism is an important veterinary pathogen, especially in young foals.

Transmission

Human infection is generally acquired through environmental exposure rather than routine person-to-person transmission.

Possible routes include:

• Inhalation of contaminated dust or aerosols

• Direct inoculation into wounds

• Exposure to contaminated soil

Pulmonary acquisition through inhalation is especially relevant to:

R. equi pneumonia

Epidemiology

Rhodococcus infections occur:

Worldwide

but remain:

Rare

The frequency of recognized R. equi infection increased substantially with the emergence of populations with severe impairment of:

Cell-mediated immunity

Major Risk Factor

The most important clinical association is:

IMMUNOCOMPROMISE

particularly impaired:

T-cell-mediated immunity

Important risk groups include patients with:

• Advanced HIV infection

• Hematologic malignancy

• Organ transplantation

• Immunosuppressive therapy

• Other significant defects in cellular immunity

High-Yield Host Pattern

Immunocompromised patient

• ●

Cavitary pneumonia

• ●

Gram-positive weakly acid-fast coccobacillus

→ Rhodococcus equi

Intracellular Survival

R. equi is capable of surviving within:

Macrophages

This intracellular behavior contributes to its ability to cause persistent infection in patients with defective:

Cell-mediated immunity

The organism’s intracellular location also has implications for antimicrobial selection.

Rhodococcus equi Pneumonia

The most important human infection caused by R. equi is:

PNEUMONIA

Pulmonary infection can have an:

• Acute

• Subacute

• Chronic

course.

Pulmonary Manifestations

Clinical findings may include:

• Fever

• Cough

• Dyspnea

• Chest discomfort

• Constitutional symptoms

• Weight loss in chronic disease

Radiographic abnormalities may include:

• Pulmonary consolidation

• Nodules

• Cavitary lesions

• Solitary pulmonary nodules

Cavitary Pneumonia

One of the most characteristic presentations is:

Cavitary pulmonary disease

This can closely resemble several other chronic pulmonary infections.

Important Differential Diagnosis

R. equi pneumonia may resemble:

Tuberculosis

Nocardiosis

and

Actinomycosis

because these infections can also produce:

Chronic pulmonary disease + nodules/cavitation

High-Yield Pulmonary Pattern

Impaired cellular immunity

• ●

Subacute/chronic pneumonia

• ●

Pulmonary cavitation

• ●

Weakly acid-fast Gram-positive organism

→ Think R. equi

Association with HIV

Isolation of R. equi from a clinically significant specimen should raise concern for:

Underlying impairment of cellular immunity

Historically, a particularly important association has been:

Advanced HIV infection

Therefore, identification of invasive R. equi infection should prompt evaluation for an underlying immunocompromising condition when one is not already known.

Important Clinical Principle

R. equi isolated from a significant clinical specimen

→ Ask:

Why is this patient’s cellular immunity impaired?

The answer may reveal an underlying:

• HIV infection

• Malignancy

• Transplant-related immunosuppression

• Immunosuppressive medication exposure

Brain Abscess

Disseminated R. equi infection can involve the:

Central nervous system

and produce:

Brain abscess

This is a serious manifestation usually associated with invasive or disseminated infection.

Osteomyelitis

The organism may infect:

Bone

causing:

Osteomyelitis

This may occur through hematogenous dissemination or local inoculation.

Prostatic Abscess

R. equi has also been reported as a cause of:

Prostatic abscess

particularly in susceptible hosts.

Bacteremia

Invasive infection may result in:

Bacteremia

Bloodstream infection can accompany:

Pulmonary or disseminated disease

and is particularly concerning in immunocompromised patients.

Lymphadenitis

Another reported manifestation is:

Lymphadenitis

This may occur as part of localized or disseminated infection.

Endophthalmitis

Ocular dissemination can result in:

Endophthalmitis

which may threaten vision and requires prompt specialist management.

Intra-Abdominal Infection

R. equi has also been isolated from patients with:

Intra-abdominal infections

Although pulmonary disease remains the classic manifestation, the organism can therefore produce:

Multisystem disease

in severely immunocompromised patients.

Disseminated Rhodococcosis

A useful concept is:

Pulmonary infection

↓

Bacteremia

↓

Hematogenous dissemination

↓

Possible involvement of:

Brain + bone + prostate + lymph nodes + eye + intra-abdominal organs

Other Rhodococcus Species

Species other than R. equi are much less frequently implicated in human infection.

The source notes that these organisms are often associated with:

Surgical infections

or other healthcare-related circumstances.

When an unusual Rhodococcus species is recovered, its clinical significance should be assessed carefully.

Diagnosis

The primary diagnostic method is:

Culture

Appropriate specimens depend on the clinical syndrome and may include:

• Sputum

• Bronchoalveolar lavage

• Blood

• Abscess material

• Tissue biopsy

• Bone specimens

• Other normally sterile fluids

Culture Characteristics

R. equi may produce colonies that develop a characteristic:

Salmon-pink to reddish coloration

with maturation.

This pigmentation can provide a useful laboratory clue.

High-Yield Laboratory Pattern

Gram-positive coccobacillus

• ●

Weak acid-fast positivity

• ●

Salmon-pink colonies

→ Think Rhodococcus equi

Diagnostic Pitfall

Because Rhodococcus may initially resemble:

Diphtheroid-like organisms

or other environmental Gram-positive bacteria, it can potentially be dismissed as a:

Contaminant

However, isolation from a normally sterile site or from a patient with compatible pulmonary disease and immunocompromise should be taken seriously.

Histopathology

Tissue infection may demonstrate organisms within:

Macrophages

consistent with the intracellular nature of R. equi.

Suppurative and granulomatous inflammatory responses may occur.

Acid-Fast Staining

R. equi may demonstrate:

Weak or variable acid-fast staining

because of lipid-containing components of its cell envelope.

This creates an important differential with:

Mycobacterium

and

Nocardia

Rhodococcus vs. Mycobacterium tuberculosis

Rhodococcus equi

→ Gram-positive coccobacillary/pleomorphic organism

→ Weakly or variably acid-fast

→ May produce salmon-pink colonies

→ Opportunistic infection

→ Cavitary pneumonia

Mycobacterium tuberculosis

→ Strongly acid-fast bacillus with conventional acid-fast staining

→ Classic cause of tuberculosis

→ Cavitary pulmonary disease, especially upper lobes

Both may cause chronic pulmonary disease in patients with HIV.

Rhodococcus vs. Nocardia

Rhodococcus equi

→ Gram-positive coccobacillus

→ Intracellular pathogen

→ Weakly acid-fast

→ Cavitary pneumonia

→ Salmon-pink pigmentation may occur

Nocardia

→ Branching filamentous Gram-positive bacterium

→ Weakly acid-fast

→ Pulmonary and CNS disease

→ Particularly important in patients with impaired cellular immunity

Thus:

Branching filamentous morphology

strongly favors Nocardia.

Rhodococcus vs. Actinomyces

Rhodococcus

→ Aerobic

→ May be weakly acid-fast

→ Opportunistic pulmonary infection

Actinomyces

→ Anaerobic or microaerophilic

→ Branching filamentous Gram-positive bacteria

→ Classically produces sulfur granules

→ Cervicofacial, thoracic, and abdominopelvic actinomycosis

Treatment

The source lists several antimicrobial agents with activity against Rhodococcus:

• Vancomycin

• Erythromycin

• Ciprofloxacin

• Imipenem

Additional treatment listed includes:

• Azithromycin

Combination Therapy

Serious R. equi infection can be difficult to eradicate because the organism is:

Intracellular

and disease frequently occurs in:

Immunocompromised patients

For severe or invasive disease, treatment commonly involves multiple active antimicrobial agents, selected according to:

Susceptibility testing + disease severity + infection site

Treatment Duration

The source emphasizes that therapy typically lasts:

Several weeks

More complicated infections—particularly cavitary pulmonary, CNS, bone, or disseminated disease—may require:

Prolonged antimicrobial therapy

Treatment duration should be individualized according to clinical and microbiologic response and the patient’s immune status.

Role of Immune Restoration

Because severe R. equi disease is strongly associated with:

Impaired cellular immunity

management should also address the underlying immune defect whenever possible.

For patients with HIV, effective:

Antiretroviral therapy

is an important component of overall management.

High-Yield Treatment Principle

Severe R. equi infection

→ Combination antimicrobial therapy

• ●

Prolonged treatment

• ●

Susceptibility testing

• ●

Improve underlying immune function when possible

Prevention

There is no specific human vaccine.

For severely immunocompromised individuals, reasonable preventive principles include:

• Avoiding unnecessary exposure to heavily contaminated soil or dust

• Appropriate wound hygiene

• Standard healthcare infection-control measures

• Effective management of underlying immunosuppression

Routine person-to-person transmission is not the major epidemiologic pattern.

High-Yield Clinical Pattern

Advanced cellular immunodeficiency

• ●

Subacute/chronic cavitary pneumonia

• ●

Weakly acid-fast Gram-positive coccobacillus

• ●

Salmon-pink colonies

→ Think RHODOCOCCUS EQUI

Exam Essentials

Genus: Rhodococcus

Most important species: R. equi

Type: Aerobic Gram-positive coccobacillus

Acid-fast staining: Weakly/variably positive

Lifestyle: Intracellular pathogen

Reservoir: Environmental, particularly soil and horse-associated environments

Distribution: Worldwide

Human disease: Rare

Major risk factor: Impaired cell-mediated immunity

Classic host: Patient with advanced HIV or another significant immunocompromising condition

Major infection: Pneumonia

Classic pulmonary finding: Cavitation or pulmonary nodules

Major mimics: Tuberculosis and nocardiosis

Other infections: Brain abscess, osteomyelitis, prostatic abscess, bacteremia, lymphadenitis, endophthalmitis, and intra-abdominal infection

Other Rhodococcus species: Often associated with surgical/healthcare-related infections

Culture clue: May develop salmon-pink/red pigmentation

Diagnosis: Culture

Source-listed treatments: Vancomycin, erythromycin, ciprofloxacin, imipenem, and azithromycin

Treatment principle: Severe disease generally requires prolonged, susceptibility-guided therapy, often with combination treatment

Important clinical action: Consider evaluation for impaired cellular immunity when invasive R. equi infection is identified

Key clinical pearl: Rhodococcus equi is a rare, aerobic Gram-positive coccobacillus that can be weakly acid-fast and survive intracellularly. Its classic presentation is subacute or chronic cavitary pneumonia in a patient with impaired cell-mediated immunity, especially advanced HIV, and it may mimic tuberculosis or nocardiosis. A clinically significant R. equi isolate should therefore prompt consideration of an underlying cellular immune defect.

Infectious Disease and Microbiology – Rhinovirus

Overview

Rhinoviruses are small, nonenveloped, single-stranded positive-sense RNA viruses and are the most frequent viral cause of the common cold. They circulate worldwide and infect primarily the upper respiratory tract.

A large number of antigenically distinct rhinovirus types exist, which helps explain why individuals can experience repeated common colds throughout life and why development of broadly protective immunity is difficult.

Classification

Group: Rhinovirus

Major disease: Common cold

Rhinoviruses belong to the:

Picornavirus family (Picornaviridae)

and are classified within the genus:

Enterovirus

Important human rhinoviruses are grouped principally into:

• Rhinovirus A

• Rhinovirus B

• Rhinovirus C

Older classifications described more than 100 serotypes.

Microbiologic Characteristics

Rhinoviruses are:

• Single-stranded RNA viruses

• Positive-sense (+) RNA

• Nonenveloped

• Small viruses

• Icosahedral in symmetry

Because the genome is positive-sense RNA, viral RNA can function directly as:

Messenger RNA (mRNA)

after entering the host cell.

High-Yield Microbiology Pattern

Small

• ●

Nonenveloped

• ●

Positive-sense ssRNA

• ●

Picornavirus

• ●

Common cold

→ Think RHINOVIRUS

Temperature Preference

Rhinoviruses replicate efficiently at temperatures around:

33°C

which approximates the temperature of the:

Nasal passages and upper respiratory tract

This contributes to their strong association with:

Upper respiratory infection

rather than predominantly systemic disease.

Acid Lability

A classic microbiologic characteristic of rhinoviruses is that they are relatively:

Acid labile

This contrasts with many enteroviruses, which are more resistant to acidic conditions and therefore can survive passage through the gastrointestinal tract.

Rhinovirus vs. Enteroviruses

Rhinovirus

→ Acid labile

→ Prefers cooler temperatures

→ Primarily upper respiratory tract

Classic enteroviruses

→ More acid stable

→ Can survive gastrointestinal conditions

→ May cause gastrointestinal, neurologic, cardiac, cutaneous, or systemic disease

Antigenic Diversity

The source describes:

More than 100 recognized serotypes

of rhinovirus.

Modern classification recognizes numerous genetically distinct rhinovirus types across groups A, B, and C.

This extensive diversity means that immunity to one type does not provide reliable protection against all others.

Clinical Consequence

Many rhinovirus types

↓

Limited cross-protective immunity

↓

Repeated infections throughout life

↓

No single broadly effective rhinovirus vaccine currently used

Incubation Period

The incubation period is usually:

2–3 days

with the source describing a range of approximately:

12 hours to 5 days

Symptoms therefore typically appear relatively soon after exposure.

Epidemiology

Rhinovirus infection occurs:

Worldwide

and affects:

All age groups

Children commonly experience multiple infections, and adults remain susceptible because of the large number of viral types.

Transmission

Rhinovirus spreads primarily through:

• Respiratory secretions

• Direct contact

• Contaminated hands and surfaces

• Respiratory droplets and aerosols

Transfer of contaminated secretions to the:

Nose or eyes

can facilitate infection.

Pathogenesis

A simplified sequence is:

Exposure to respiratory secretions

↓

Virus reaches nasal/upper respiratory mucosa

↓

Attachment to susceptible epithelial cells

↓

Viral replication

↓

Local inflammatory response

↓

Common cold symptoms

Much of the symptom complex results from the host’s:

Inflammatory response

rather than extensive destruction of respiratory epithelium.

Common Cold

The classic clinical syndrome is:

COMMON COLD

Typical manifestations include:

• Rhinorrhea

• Nasal congestion

• Sneezing

• Sore throat

• Cough

• Malaise

• Headache in some patients

Fever is generally:

Absent or low grade

especially in adults.

High-Yield Clinical Pattern

Rhinorrhea

• ●

Sneezing

• ●

Nasal congestion

• ●

Mild sore throat/cough

• ●

Little or no fever

→ Think viral common cold, with rhinovirus the classic cause

Duration

Symptoms usually:

Peak during the first several days

and then gradually improve.

Cough and some upper respiratory symptoms may persist longer than the initial nasal symptoms.

Complications

Although rhinovirus infection is usually mild and self-limited, it may contribute to:

• Asthma exacerbations

• COPD exacerbations

• Acute sinus symptoms

• Otitis media, particularly in children

• Lower respiratory disease in susceptible patients

Rhinoviruses are particularly important viral triggers of:

Asthma exacerbations

Diagnosis

For an uncomplicated common cold:

No diagnostic investigation is usually necessary.

Diagnosis is generally:

Clinical

based on the characteristic upper respiratory syndrome.

Laboratory Diagnosis

The source lists:

Cell culture

as a diagnostic method.

However, routine culture is rarely required for uncomplicated rhinovirus infection.

When specific viral identification is clinically necessary, modern respiratory molecular assays such as:

NAAT/PCR

are generally more useful than conventional viral culture.

High-Yield Diagnostic Principle

Typical uncomplicated common cold

→ Clinical diagnosis

→ Usually no laboratory testing required

Treatment

Treatment is:

SYMPTOMATIC AND SUPPORTIVE

There is no routinely used specific antiviral therapy for uncomplicated rhinovirus infection.

Supportive Management

Depending on symptoms, supportive care may include:

• Adequate fluids

• Rest

• Analgesic/antipyretic medications when needed

• Measures to relieve nasal congestion

• Saline nasal preparations

Most infections resolve spontaneously.

Antibiotics

Because rhinovirus is:

Viral

antibiotics do not treat an uncomplicated rhinovirus infection.

Unnecessary antibiotic therapy should therefore be avoided unless there is evidence of a separate:

Bacterial infection

High-Yield Treatment Pattern

Rhinovirus common cold

→ Supportive care

NOT

→ Routine antibiotics

Prevention

The source emphasizes:

Frequent handwashing

Because respiratory secretions can transmit the virus, additional measures include:

• Covering coughs and sneezes

• Appropriate disposal of nasal and oral secretions

• Avoiding touching the eyes and nose with contaminated hands

• Cleaning frequently touched surfaces when appropriate

• Limiting close contact with others while acutely symptomatic

Rhinovirus vs. Influenza

Rhinovirus

→ Predominantly upper respiratory symptoms

→ Rhinorrhea and sneezing prominent

→ Fever usually absent or mild

→ Systemic symptoms generally mild

→ Common cold

Influenza

→ More abrupt onset

→ Fever often prominent

→ Myalgia and headache common

→ Marked fatigue/systemic illness

→ Can cause significant lower respiratory complications

Rhinovirus vs. RSV

Rhinovirus

→ Classic cause of common cold

→ Upper respiratory symptoms dominate

RSV

→ Particularly important cause of bronchiolitis in infants

→ Wheezing and lower respiratory involvement may be prominent

Both can cause disease beyond these classic patterns.

Rhinovirus vs. Parainfluenza Virus

Rhinovirus

→ Common cold

→ Rhinorrhea, congestion, sneezing

Parainfluenza virus

→ Classic cause of croup

→ Barking cough

→ Inspiratory stridor

→ Hoarseness

Rhinovirus vs. Coronavirus

Both rhinoviruses and seasonal human coronaviruses can cause:

Common cold-like upper respiratory illness

Clinical symptoms alone may not reliably identify the specific virus.

However, rhinovirus remains one of the:

Most common causes of the common cold

High-Yield Clinical Pattern

2–3 day incubation

• ●

Rhinorrhea

• ●

Sneezing and congestion

• ●

Mild upper respiratory illness

• ●

Nonenveloped positive-sense RNA virus

→ Think RHINOVIRUS

Exam Essentials

Virus: Rhinovirus

Family: Picornaviridae

Modern genus: Enterovirus

Genome: Positive-sense single-stranded RNA (+ssRNA)

Envelope: Absent

Capsid: Icosahedral

Size: Small

Antigenic diversity: Numerous distinct rhinovirus types; historically described as >100 serotypes

Temperature preference: Approximately 33°C, favoring the upper respiratory tract

Acid stability: Acid labile

Incubation: Usually 2–3 days

Distribution: Worldwide

Major disease: Common cold

Classic symptoms: Rhinorrhea, sneezing, nasal congestion, sore throat, and cough

Important complication/association: Asthma exacerbation

Transmission: Respiratory secretions and contact with contaminated hands/surfaces

Diagnosis: Usually clinical

Routine testing: Generally unnecessary

Modern laboratory method when needed: Molecular respiratory testing/NAAT

Treatment: Symptomatic/supportive

Antibiotics: Not indicated for uncomplicated infection

Prevention: Hand hygiene + respiratory hygiene

Vaccine: No routinely available rhinovirus vaccine

Key clinical pearl: Rhinovirus is a small, nonenveloped, positive-sense single-stranded RNA picornavirus and the classic cause of the common cold. Remember its preference for the cooler environment of the upper respiratory tract, relative acid lability, enormous antigenic diversity, and typical presentation of rhinorrhea, sneezing, and nasal congestion with little or no fever. Diagnosis is usually clinical and treatment is supportive.

Infectious Disease and Microbiology – Rhinosporidium seeberi

Overview

Rhinosporidium seeberi is an unusual aquatic-associated pathogen that causes rhinosporidiosis, a chronic granulomatous disease characterized by friable, polyp-like lesions of mucosal surfaces, particularly the nasal cavity and conjunctiva.

The organism was historically regarded as a fungus, but modern molecular classification places it among the Mesomycetozoea (Ichthyosporea), a group of aquatic protistan organisms near the animal-fungal divergence. The hallmark diagnostic finding is a large, thick-walled spherical sporangium containing numerous endospores (sporangiospores) within affected tissue.

Classification

Genus: Rhinosporidium

Species: Rhinosporidium seeberi

Disease: Rhinosporidiosis

Historically:

Considered a fungus

Modern classification:

Aquatic protistan/eukaryotic organism within Mesomycetozoea

Therefore, rhinosporidiosis is traditionally discussed with fungal infections even though R. seeberi is not considered a true fungus.

Microbiologic Characteristics

The characteristic tissue morphology consists of:

• Large, round sporangia

• Thick sporangial walls

• Numerous internal sporangiospores/endospores

• Sporangia at different stages of maturation

Mature sporangia may contain numerous developing spores of varying maturity.

High-Yield Microbiology Pattern

Large spherical sporangium

• ●

Numerous internal endospores

• ●

Nasal polyp

→ Think Rhinosporidium seeberi

Sporangia

The most characteristic feature of R. seeberi is the formation of:

Large spherical sporangia

within infected tissue.

These structures can become much larger than typical fungal yeast cells and contain numerous internal:

Endospores (sporangiospores)

Sporangiospores

As the sporangium matures:

Immature spores

↓

Develop into

↓

Mature spores

↓

Released from the sporangium

↓

Potentially contribute to local propagation of infection

Thus, tissue may contain sporangia at:

Different stages of development

High-Yield Histopathology

Very large thick-walled spherical structure

• ●

Numerous internal daughter spores

→ Rhinosporidium seeberi

Epidemiology

Rhinosporidiosis is:

Rare worldwide

but occurs particularly in:

• India

• Sri Lanka

Cases have also been reported from:

• Africa

• South America

• Other regions

The disease is particularly associated with tropical environments.

Environmental Association

R. seeberi is associated with:

Aquatic environments

Exposure to:

Pond or stagnant water

has traditionally been linked to rhinosporidiosis.

Infection is thought to occur when the organism gains access to traumatized:

Nasal, ocular, or other mucosal epithelium

High-Yield Exposure Pattern

India or Sri Lanka

• ●

Pond/stagnant-water exposure

• ●

Chronic nasal polyp

→ Think rhinosporidiosis

Rhinosporidiosis

The disease caused by R. seeberi is:

RHINOSPORIDIOSIS

It is typically a:

Chronic, localized mucosal infection

The most frequently involved sites are:

Nasal cavity

and

Conjunctiva

Nasal Rhinosporidiosis

The classic manifestation is a:

Chronic nasal polyp-like lesion

The lesion is often:

• Painless

• Slowly progressive

• Polypoid

• Friable

• Red or reddish

• Prone to bleeding when traumatized

Strawberry-Like Appearance

A classic description of the lesion is:

“Strawberry-like”

The surface may contain visible whitish dots representing underlying mature:

Sporangia

This gross appearance can provide an important clinical clue.

Classic Clinical Pattern

Chronic painless nasal mass

• ●

Red/friable polyp

• ●

White dots on surface

• ●

India/Sri Lanka exposure

→ Think Rhinosporidium seeberi

Nasal Symptoms

Depending on lesion size and location, patients may develop:

• Nasal obstruction

• Nasal discharge

• Epistaxis

• Foreign-body sensation

• Progressive polypoid mass

Because the lesion can be highly vascular and friable:

Bleeding

may occur readily.

Conjunctival Rhinosporidiosis

The second major presentation involves the:

Conjunctiva

Patients may develop:

Polypoid conjunctival lesions

that resemble other benign ocular growths.

Other ocular structures can occasionally be involved.

High-Yield Ocular Pattern

Chronic painless conjunctival polyp

• ●

Endemic-region exposure

• ●

Large sporangia containing numerous endospores

→ R. seeberi

Other Sites

Although nasal and conjunctival disease dominate, rhinosporidiosis can occasionally involve other mucosal or cutaneous sites.

Disseminated disease is:

Rare

The overwhelming classic presentation remains:

Localized nasal or conjunctival polyposis

Diagnosis

Diagnosis is established by demonstrating:

Characteristic sporangia in tissue biopsy specimens

This is the central diagnostic method.

Histopathology

Biopsy demonstrates:

Large, thick-walled sporangia

containing:

Numerous endospores

Sporangia may be present at multiple stages of maturation.

The surrounding tissue commonly demonstrates a:

Chronic granulomatous inflammatory response

Diagnostic Pattern

Polyp biopsy

↓

Large round sporangia

↓

Numerous internal spores

↓

Diagnosis:

Rhinosporidium seeberi

Culture

Unlike many conventional fungal pathogens, R. seeberi has historically been extremely difficult to maintain in routine artificial culture.

Therefore, diagnosis relies primarily on:

Clinical appearance + histopathology

rather than routine fungal culture.

Differential Diagnosis

A chronic nasal polypoid lesion may initially resemble:

• Conventional inflammatory nasal polyp

• Benign neoplasm

• Malignancy

• Other chronic granulomatous infections

The identification of:

Large endospore-containing sporangia

is highly characteristic of rhinosporidiosis.

Rhinosporidium vs. Coccidioides

Both can produce:

Spherule/sporangium-like structures containing internal spores

but their clinical patterns are very different.

Rhinosporidium seeberi

→ Large sporangia containing numerous endospores

→ Nasal/conjunctival polyps

→ Aquatic exposure

→ India/Sri Lanka association

Coccidioides

→ Spherules containing endospores in tissue

→ Primarily pulmonary infection after inhalation

→ Associated with arid environments of the Americas

Thus, the:

Clinical site + geographic/exposure history

helps distinguish them.

Treatment

The principal treatment is:

Surgical excision

of the affected:

Nasal or conjunctival polyp

Surgical Management

Treatment generally involves:

Complete excision of the lesion

with attention to its base.

Because residual organisms can produce recurrent disease, destruction of the lesion base, such as through:

Electrocauterization

has traditionally been used to reduce recurrence.

Recurrence

An important feature is:

RECURRENCE AFTER SURGERY

Recurrence may result from:

• Incomplete excision

• Residual sporangia

• Local implantation of endospores during surgery

Therefore, careful removal and management of the lesion base are important.

High-Yield Treatment Pattern

Rhinosporidiosis

→ Surgical excision

• ●

Cauterization of lesion base when appropriate

→ Reduce risk of recurrence

Antimicrobial Therapy

The source notes that the effectiveness of conventional:

Antifungal therapy

is uncertain.

This is biologically understandable because:

R. seeberi is not a true fungus.

Consequently, conventional antifungal drugs are not reliably effective.

Dapsone

Dapsone has historically been used as an adjunct in some cases of rhinosporidiosis, particularly recurrent or difficult disease, although surgery remains the cornerstone of management and the evidence for medical therapy is limited.

Prevention

There is no vaccine.

In endemic areas, prevention may include reducing exposure of traumatized nasal or ocular mucosa to potentially contaminated:

Stagnant or pond water

However, because the precise ecology and transmission mechanisms are incompletely understood, no preventive strategy provides complete protection.

Key Pathogenesis Sequence

Aquatic environmental exposure

↓

Entry through traumatized mucosa

↓

Local development of sporangia

↓

Production of numerous endospores

↓

Chronic granulomatous inflammation

↓

Polypoid nasal/conjunctival lesion

High-Yield Clinical Pattern

India/Sri Lanka

• ●

Pond or stagnant-water exposure

• ●

Chronic painless friable nasal polyp

• ●

Large sporangia filled with endospores

→ RHINOSPORIDIUM SEEBERI

Exam Essentials

Genus: Rhinosporidium

Species: R. seeberi

Disease: Rhinosporidiosis

Historical classification: Fungus

Modern classification: Mesomycetozoean aquatic protistan/eukaryotic organism

Distribution: Worldwide but particularly associated with India and Sri Lanka

Environmental association: Aquatic environments, especially stagnant/pond water

Major site: Nasal mucosa

Second classic site: Conjunctiva

Typical lesion: Chronic painless polypoid mass

Gross appearance: Often red, friable, and strawberry-like

Characteristic histology: Large thick-walled sporangia containing numerous endospores

Diagnosis: Tissue biopsy/histopathology

Routine culture: Generally not useful

Treatment: Surgical excision

Adjunctive surgical principle: Treatment of/cauterization of the lesion base may reduce recurrence

Recurrence: Can occur after surgery

Antifungal therapy: No reliably established efficacy

Possible adjunct: Dapsone has historically been used in selected cases

Key clinical pearl: Rhinosporidium seeberi should be remembered as the cause of chronic, usually painless nasal or conjunctival polypoid lesions, especially in patients from India or Sri Lanka with aquatic exposure. The diagnostic hallmark is a biopsy showing enormous thick-walled sporangia packed with numerous endospores. Surgical excision is the cornerstone of treatment, but recurrence can occur, and conventional antifungal therapy is not reliably effective because the organism is not a true fungus.

Classification Genus: Rhinosporidium

Species: Rhinosporidium seeberi

Disease: Rhinosporidiosis Historically: Considered a fungus Modern classification: Aquatic protistan/eukaryotic organism within Mesomycetozoea Therefore, rhinosporidiosis is traditionally discussed with fungal infections even though R. seeberi is not considered a true fungus.

Microbiologic Characteristics The characteristic tissue morphology consists of: • Large, round sporangia

• Thick sporangial walls

• Numerous internal sporangiospores/endospores

• Sporangia at different stages of maturation Mature sporangia may contain numerous developing spores of varying maturity.

High-Yield Microbiology Pattern Large spherical sporangium  ●  Numerous internal endospores  ●  Nasal polyp → Think Rhinosporidium seeberi

Sporangia The most characteristic feature of R. seeberi is the formation of: Large spherical sporangia within infected tissue. These structures can become much larger than typical fungal yeast cells and contain numerous internal: Endospores (sporangiospores)

Sporangiospores As the sporangium matures: Immature spores ↓ Develop into ↓ Mature spores ↓ Released from the sporangium ↓ Potentially contribute to local propagation of infection Thus, tissue may contain sporangia at: Different stages of development

High-Yield Histopathology Very large thick-walled spherical structure  ●  Numerous internal daughter spores → Rhinosporidium seeberi

Epidemiology Rhinosporidiosis is: Rare worldwide but occurs particularly in: • India

• Sri Lanka Cases have also been reported from: • Africa

• South America

• Other regions The disease is particularly associated with tropical environments.

Environmental Association R. seeberi is associated with: Aquatic environments Exposure to: Pond or stagnant water has traditionally been linked to rhinosporidiosis. Infection is thought to occur when the organism gains access to traumatized: Nasal, ocular, or other mucosal epithelium

High-Yield Exposure Pattern India or Sri Lanka  ●  Pond/stagnant-water exposure  ●  Chronic nasal polyp → Think rhinosporidiosis

Rhinosporidiosis The disease caused by R. seeberi is: RHINOSPORIDIOSIS It is typically a: Chronic, localized mucosal infection The most frequently involved sites are: Nasal cavity and Conjunctiva

Nasal Rhinosporidiosis The classic manifestation is a: Chronic nasal polyp-like lesion The lesion is often: • Painless

• Slowly progressive

• Polypoid

• Friable

• Red or reddish

• Prone to bleeding when traumatized

Strawberry-Like Appearance A classic description of the lesion is: “Strawberry-like” The surface may contain visible whitish dots representing underlying mature: Sporangia This gross appearance can provide an important clinical clue.

Classic Clinical Pattern Chronic painless nasal mass  ●  Red/friable polyp  ●  White dots on surface  ●  India/Sri Lanka exposure → Think Rhinosporidium seeberi

Nasal Symptoms Depending on lesion size and location, patients may develop: • Nasal obstruction

• Nasal discharge

• Epistaxis

• Foreign-body sensation

• Progressive polypoid mass Because the lesion can be highly vascular and friable: Bleeding may occur readily.

Conjunctival Rhinosporidiosis The second major presentation involves the: Conjunctiva Patients may develop: Polypoid conjunctival lesions that resemble other benign ocular growths. Other ocular structures can occasionally be involved.

High-Yield Ocular Pattern Chronic painless conjunctival polyp  ●  Endemic-region exposure  ●  Large sporangia containing numerous endospores → R. seeberi

Other Sites Although nasal and conjunctival disease dominate, rhinosporidiosis can occasionally involve other mucosal or cutaneous sites. Disseminated disease is: Rare The overwhelming classic presentation remains: Localized nasal or conjunctival polyposis

Diagnosis Diagnosis is established by demonstrating: Characteristic sporangia in tissue biopsy specimens This is the central diagnostic method.

Histopathology Biopsy demonstrates: Large, thick-walled sporangia containing: Numerous endospores Sporangia may be present at multiple stages of maturation. The surrounding tissue commonly demonstrates a: Chronic granulomatous inflammatory response

Diagnostic Pattern Polyp biopsy ↓ Large round sporangia ↓ Numerous internal spores ↓ Diagnosis: Rhinosporidium seeberi

Culture Unlike many conventional fungal pathogens, R. seeberi has historically been extremely difficult to maintain in routine artificial culture. Therefore, diagnosis relies primarily on: Clinical appearance + histopathology rather than routine fungal culture.

Differential Diagnosis A chronic nasal polypoid lesion may initially resemble: • Conventional inflammatory nasal polyp

• Benign neoplasm

• Malignancy

• Other chronic granulomatous infections The identification of: Large endospore-containing sporangia is highly characteristic of rhinosporidiosis.

Rhinosporidium vs. Coccidioides Both can produce: Spherule/sporangium-like structures containing internal spores but their clinical patterns are very different. Rhinosporidium seeberi → Large sporangia containing numerous endospores

→ Nasal/conjunctival polyps

→ Aquatic exposure

→ India/Sri Lanka association Coccidioides → Spherules containing endospores in tissue

→ Primarily pulmonary infection after inhalation

→ Associated with arid environments of the Americas Thus, the: Clinical site + geographic/exposure history helps distinguish them.

Treatment The principal treatment is: Surgical excision of the affected: Nasal or conjunctival polyp

Surgical Management Treatment generally involves: Complete excision of the lesion with attention to its base. Because residual organisms can produce recurrent disease, destruction of the lesion base, such as through: Electrocauterization has traditionally been used to reduce recurrence.

Recurrence An important feature is: RECURRENCE AFTER SURGERY Recurrence may result from: • Incomplete excision

• Residual sporangia

• Local implantation of endospores during surgery Therefore, careful removal and management of the lesion base are important.

High-Yield Treatment Pattern Rhinosporidiosis → Surgical excision  ●  Cauterization of lesion base when appropriate → Reduce risk of recurrence

Antimicrobial Therapy The source notes that the effectiveness of conventional: Antifungal therapy is uncertain. This is biologically understandable because: R. seeberi is not a true fungus. Consequently, conventional antifungal drugs are not reliably effective.

Dapsone Dapsone has historically been used as an adjunct in some cases of rhinosporidiosis, particularly recurrent or difficult disease, although surgery remains the cornerstone of management and the evidence for medical therapy is limited.

Prevention There is no vaccine. In endemic areas, prevention may include reducing exposure of traumatized nasal or ocular mucosa to potentially contaminated: Stagnant or pond water However, because the precise ecology and transmission mechanisms are incompletely understood, no preventive strategy provides complete protection.

Key Pathogenesis Sequence Aquatic environmental exposure ↓ Entry through traumatized mucosa ↓ Local development of sporangia ↓ Production of numerous endospores ↓ Chronic granulomatous inflammation ↓ Polypoid nasal/conjunctival lesion

High-Yield Clinical Pattern India/Sri Lanka  ●  Pond or stagnant-water exposure  ●  Chronic painless friable nasal polyp  ●  Large sporangia filled with endospores → RHINOSPORIDIUM SEEBERI

Exam Essentials Genus: Rhinosporidium

Species: R. seeberi

Disease: Rhinosporidiosis

Historical classification: Fungus

Modern classification: Mesomycetozoean aquatic protistan/eukaryotic organism

Distribution: Worldwide but particularly associated with India and Sri Lanka

Environmental association: Aquatic environments, especially stagnant/pond water

Major site: Nasal mucosa

Second classic site: Conjunctiva

Typical lesion: Chronic painless polypoid mass

Gross appearance: Often red, friable, and strawberry-like

Characteristic histology: Large thick-walled sporangia containing numerous endospores

Diagnosis: Tissue biopsy/histopathology

Routine culture: Generally not useful

Treatment: Surgical excision

Adjunctive surgical principle: Treatment of/cauterization of the lesion base may reduce recurrence

Recurrence: Can occur after surgery

Antifungal therapy: No reliably established efficacy

Possible adjunct: Dapsone has historically been used in selected cases

Key clinical pearl: Rhinosporidium seeberi should be remembered as the cause of chronic, usually painless nasal or conjunctival polypoid lesions, especially in patients from India or Sri Lanka with aquatic exposure. The diagnostic hallmark is a biopsy showing enormous thick-walled sporangia packed with numerous endospores. Surgical excision is the cornerstone of treatment, but recurrence can occur, and conventional antifungal therapy is not reliably effective because the organism is not a true fungus.

Infectious Disease and Microbiology – Psychrobacter immobilis

Overview

Psychrobacter immobilis is a Gram-negative coccobacillus and an uncommon opportunistic pathogen. Members of the genus Psychrobacter are notable for their ability to survive and grow in cold environments, and organisms within this group have been isolated from food, environmental sources, and clinical specimens.

Human disease caused by P. immobilis is rare, with only a limited number of documented infections. The organism has been recovered from blood, urine, and wounds, but because clinical experience is limited, treatment should be guided by culture and antimicrobial susceptibility testing rather than a standard empiric regimen.

Classification

Genus: Psychrobacter

Species: Psychrobacter immobilis

Organism type: Gram-negative coccobacillus

The taxonomy and identification of some organisms historically assigned to Psychrobacter or closely related genera have undergone revision, so older reports may contain uncertain or outdated species assignments.

Microbiologic Characteristics

Psychrobacter organisms are generally:

• Gram-negative coccobacilli

• Aerobic

• Nonmotile

• Non-spore-forming

• Usually oxidase positive

• Usually catalase positive

• Capable of surviving or growing at relatively low temperatures

Their short, plump morphology can sometimes make them appear almost coccal on Gram stain.

High-Yield Microbiology Pattern

Gram-negative coccobacillus

• ●

Cold-tolerant environmental organism

• ●

Rare opportunistic infection

→ Consider Psychrobacter

Psychrotolerance

The name:

Psychrobacter

reflects the organism’s association with:

Cold environments

Members of the genus can tolerate and, depending on the species and conditions, grow at temperatures lower than those tolerated by many conventional human pathogens.

This explains their recovery from:

• Refrigerated foods

• Cold environmental habitats

• Marine environments

• Other low-temperature ecological niches

Incubation Period

The incubation period is:

Unknown

Because P. immobilis is a rare opportunistic pathogen rather than an organism producing a well-defined transmissible syndrome, there is no characteristic incubation interval.

Epidemiology

P. immobilis has been isolated from:

Food

and is associated with:

Cold environments

Psychrobacter organisms are broadly environmental and have been recovered from a variety of ecological sources.

Human infection remains:

Uncommon

Clinical Significance

An important principle when Psychrobacter is isolated from a clinical specimen is determining whether the isolate represents:

True infection

or

Colonization/contamination

This distinction depends on the:

• Clinical syndrome

• Specimen source

• Host factors

• Reproducibility of the culture

• Presence of systemic inflammatory findings

Bloodstream Infection

P. immobilis has been isolated from:

Blood

and rare cases of clinically significant:

Bacteremia

have been reported.

Isolation from multiple blood cultures in a patient with compatible signs of infection provides stronger evidence for true invasive disease.

High-Yield Blood Culture Pattern

Unusual Gram-negative coccobacillus

• ●

Repeated positive blood cultures

• ●

Compatible systemic illness

→ Consider true Psychrobacter bacteremia rather than automatically dismissing the isolate

Urinary Isolation

The organism has also been recovered from:

Urine specimens

Clinical significance should be assessed using the same principles applied to other unusual urinary isolates.

Evidence supporting true UTI includes:

• Urinary symptoms

• Pyuria

• Significant bacterial growth

• Repeated isolation

• Appropriate host risk factors

Wound Infection

P. immobilis has been isolated from:

Wound specimens

Because wounds can contain colonizing environmental organisms, recovery from a superficial specimen does not necessarily prove invasive infection.

True wound infection becomes more likely when there is:

Clinical inflammation

• ●

Deep-tissue isolation

• ●

Compatible microbiologic findings

Other Psychrobacter Infections

Although the source specifically discusses P. immobilis, other members of the genus Psychrobacter have occasionally been implicated in human disease.

Reported infections within the genus have included:

• Bacteremia

• Wound and soft-tissue infections

• Urinary infection

• Other rare invasive infections

Overall, however:

Human disease is uncommon.

Diagnosis

The primary diagnostic method is:

Culture

Depending on the clinical presentation, specimens may include:

• Blood

• Urine

• Wound material

• Deep tissue

• Other normally sterile specimens

Laboratory Identification

Accurate species identification may be challenging because:

• Psychrobacter is uncommon in clinical laboratories

• Historical taxonomy has changed

• Phenotypically similar organisms may be confused with related Gram-negative bacteria

Modern laboratory identification methods can improve species-level classification.

Interpretation of Culture

Because the organism is rare, a positive culture should always be interpreted in:

Clinical context

Particularly convincing evidence of true infection includes:

Isolation from a normally sterile site

• ●

Repeated recovery

• ●

Compatible clinical disease

Treatment

There are:

Insufficient published clinical data

to establish a single standard treatment regimen specifically for P. immobilis infection.

Therefore, antimicrobial selection should be based primarily on:

In vitro antimicrobial susceptibility testing

Treatment Principle

Culture

↓

Confirm organism identification

↓

Perform susceptibility testing

↓

Select an active antimicrobial

↓

Assess for an underlying source

↓

Provide source control when necessary

Why Susceptibility Testing Matters

Because Psychrobacter infections are:

Rare

there are insufficient clinical data to confidently recommend one antimicrobial regimen for every case.

Therefore, therapy should account for:

• Susceptibility results

• Site of infection

• Severity

• Host immune status

• Renal and hepatic function

• Presence of a removable infectious source

Source Control

When infection involves a wound or another localized source, management may also require:

• Wound cleaning

• Drainage of infected collections

• Debridement when appropriate

• Removal of infected foreign material when relevant

Thus, management should not rely solely on antimicrobial therapy when a correctable source is present.

Psychrobacter vs. Acinetobacter

These organisms can have some superficial microbiologic similarities.

Psychrobacter

→ Gram-negative coccobacillus

→ Usually oxidase positive

→ Associated with cold environments

→ Rare human pathogen

Acinetobacter

→ Gram-negative coccobacillus

→ Oxidase negative

→ Important healthcare-associated pathogen

→ A. baumannii can exhibit extensive multidrug resistance

The:

Oxidase reaction

can therefore be a useful distinguishing clue.

Psychrobacter vs. Moraxella

Both may appear as:

Gram-negative coccoid or coccobacillary organisms

and both are often:

Oxidase positive

However, Psychrobacter is particularly associated with:

Environmental and cold-tolerant organisms

whereas Moraxella catarrhalis is a well-established human respiratory pathogen.

Prevention

There are no specific preventive measures or vaccines directed against P. immobilis because human disease is:

Extremely uncommon

General principles include:

• Appropriate wound hygiene

• Proper handling of invasive devices

• Standard infection-control practices

• Proper food handling

High-Yield Clinical Pattern

Cold-associated environmental organism

• ●

Gram-negative coccobacillus

• ●

Rare isolation from blood, urine, or wounds

→ Think Psychrobacter immobilis

Exam Essentials

Genus: Psychrobacter

Species: P. immobilis

Type: Gram-negative coccobacillus

Metabolism: Generally aerobic

Motility: Nonmotile

Oxidase: Usually positive

Catalase: Usually positive

Environmental feature: Cold tolerant/psychrotolerant

Reservoir: Environmental sources and food, particularly in colder settings

Incubation: Unknown

Human infection: Very rare

Clinical specimens: Blood, urine, and wounds

Possible disease: Bacteremia, UTI, and wound infection

Diagnosis: Culture

Diagnostic challenge: Uncommon organism with historically evolving taxonomy and possible identification difficulties

Standard treatment: Not established

Treatment principle: Antimicrobial susceptibility-guided therapy

Additional management: Source control when clinically indicated

Key clinical pearl: Psychrobacter immobilis is a rare, cold-tolerant Gram-negative coccobacillus associated primarily with environmental and food sources. Human disease is uncommon, but the organism has been recovered from blood, urine, and wounds. Because clinical treatment data are sparse and taxonomy has historically been difficult, a clinically significant isolate should be accurately identified and treated according to in vitro antimicrobial susceptibility results rather than a fixed empiric regimen.

Infectious Disease and Microbiology – Pseudomonas luteola

Overview

Pseudomonas luteola is a Gram-negative bacillus that is an uncommon cause of human infection. It was formerly known as Chryseomonas luteola and is encountered primarily as an opportunistic pathogen.

Human infections are rare but have been reported worldwide. Important clinical manifestations include bacteremia/septicemia, central venous catheter-associated infection, wound infection, peritoneal dialysis-associated peritonitis, prosthetic valve endocarditis, and meningitis.

Classification

Genus: Pseudomonas

Species: Pseudomonas luteola

Former name: Chryseomonas luteola

Organism type: Gram-negative bacillus

Microbiologic Characteristics

P. luteola is a:

• Gram-negative bacillus

• Environmental organism

• Opportunistic pathogen

• Rare cause of invasive human infection

An important historical laboratory characteristic is the production of:

Yellow-pigmented colonies

The species name luteola reflects this yellow pigmentation.

High-Yield Microbiology Pattern

Gram-negative bacillus

• ●

Yellow-pigmented colonies

• ●

Rare opportunistic infection

• ●

Foreign body or catheter

→ Consider Pseudomonas luteola

Epidemiology

P. luteola has a:

Worldwide distribution

However, human infection is:

Rare

The organism is primarily environmental and may be encountered in:

• Soil

• Water

• Moist environmental sources

Human disease generally occurs opportunistically rather than as a common community infection.

Risk Factors

Reported infections frequently occur in patients with:

• Central venous catheters

• Prosthetic cardiac material

• Peritoneal dialysis catheters

• Recent surgery or trauma

• Open wounds

• Other invasive medical devices

• Significant underlying disease

Thus, the presence of:

Foreign material

is an important clinical clue.

Septicemia and Bacteremia

One of the important manifestations is:

Septicemia/bacteremia

Some cases may be:

Polymicrobial

The source particularly emphasizes an association with:

Central venous catheters

Central Venous Catheter Infection

A central venous catheter can provide a surface for:

Bacterial adherence

and potentially persistent bloodstream infection.

A typical sequence is:

Environmental organism

↓

Contamination or colonization of device

↓

Catheter-associated infection

↓

Bacteremia/septicemia

High-Yield Clinical Pattern

Central venous catheter

• ●

Unusual Gram-negative bacillus

• ●

Bacteremia

→ Consider an opportunistic environmental organism such as P. luteola

Polymicrobial Infection

The source notes that septicemia may sometimes be:

Polymicrobial

Therefore, isolation of P. luteola does not necessarily mean that it is the only organism contributing to the infection.

Management should address:

All clinically significant pathogens

identified from appropriate cultures.

Wound Infection

P. luteola can cause:

Wound infections

This is consistent with its environmental reservoir and opportunistic behavior.

Potential settings include:

• Traumatic wounds

• Surgical wounds

• Contaminated tissue

• Patients with impaired host defenses

Peritoneal Dialysis-Associated Peritonitis

An important manifestation is:

Peritonitis

in patients receiving:

Peritoneal dialysis

The dialysis catheter provides a potential route by which environmental organisms can enter the peritoneal cavity.

High-Yield Dialysis Pattern

Peritoneal dialysis

• ●

Peritonitis

• ●

Rare environmental Gram-negative bacillus

→ Consider Pseudomonas luteola

Prosthetic Valve Endocarditis

P. luteola has also been reported as a cause of:

Prosthetic valve endocarditis

The presence of:

Prosthetic cardiac material

provides a surface that may facilitate persistent infection.

High-Yield Endocarditis Pattern

Prosthetic heart valve

• ●

Endocarditis

• ●

Unusual environmental Gram-negative bacillus

→ Consider P. luteola

Meningitis

Rare cases of:

Meningitis

have also been reported.

This represents an uncommon but potentially serious invasive manifestation.

Diagnosis

The primary diagnostic method is:

Culture

Depending on the clinical syndrome, appropriate specimens may include:

• Blood

• Catheter-associated blood cultures

• Wound specimens

• Peritoneal dialysis fluid

• Cerebrospinal fluid

• Other normally sterile specimens

Organism Identification

Because P. luteola is uncommon, accurate laboratory identification is important.

The historical name:

Chryseomonas luteola

may appear in older literature.

Recognition of the organism as a potential pathogen is especially important when it is repeatedly recovered from:

Normally sterile sites

or in association with:

Intravascular/prosthetic devices

Contamination vs. True Infection

Because P. luteola is an environmental organism, an unusual culture result should be interpreted within the clinical context.

True infection is more likely when there is:

• Compatible clinical disease

• Repeated positive cultures

• Isolation from a normally sterile site

• Central venous catheter involvement

• Prosthetic material

• Peritoneal dialysis-associated infection

• Appropriate inflammatory findings

Treatment

The source lists:

Ceftazidime

as the principal treatment.

However, because P. luteola infections are uncommon and susceptibility patterns can vary, treatment should ideally be guided by:

Culture and antimicrobial susceptibility testing

Additional Treatment Options

The source lists:

• Ureidopenicillins

• Aminoglycosides

• Imipenem

• Meropenem

• Ciprofloxacin

The appropriate antimicrobial depends on:

• Susceptibility results

• Site of infection

• Severity

• Renal function

• Presence of prosthetic or catheter material

Source Control

Because many reported infections involve:

Foreign material

management may require more than antimicrobial therapy.

Possible interventions include:

• Removal or replacement of an infected central venous catheter

• Management of an infected peritoneal dialysis catheter

• Debridement of an infected wound

• Evaluation of infected prosthetic cardiac material

High-Yield Treatment Principle

Device-associated P. luteola infection

→ Culture and susceptibility-guided antibiotics

• ●

→ Appropriate source control

Pseudomonas luteola vs. Pseudomonas aeruginosa

Although both carry the Pseudomonas name, they should not automatically be considered clinically identical.

Pseudomonas aeruginosa

→ Major human opportunistic pathogen

→ Common healthcare-associated infections

→ Characteristic blue-green pigments

→ Numerous well-established virulence factors

→ Frequently multidrug resistant

Pseudomonas luteola

→ Rare human pathogen

→ Environmental organism

→ Historically called Chryseomonas luteola

→ Characteristically associated with yellow pigmentation

→ Reported particularly with catheters and prosthetic material

Device-Associated Disease

A useful way to remember P. luteola is:

RARE ENVIRONMENTAL GRAM-NEGATIVE BACILLUS

• ●

FOREIGN BODY

The important foreign-body settings include:

Central venous catheter

Peritoneal dialysis catheter

and

Prosthetic heart valve

High-Yield Clinical Pattern

Rare environmental Gram-negative bacillus

• ●

Yellow-pigmented colonies

• ●

Central venous catheter-associated bacteremia

→ Think Pseudomonas luteola

Exam Essentials

Genus: Pseudomonas

Species: P. luteola

Former name: Chryseomonas luteola

Type: Gram-negative bacillus

Distribution: Worldwide

Frequency: Rare human infection

Reservoir: Primarily environmental

Pigment: Characteristically yellow

Clinical behavior: Opportunistic pathogen

Major infection: Bacteremia/septicemia

Important association: Central venous catheters

Other infections: Wound infection, peritoneal dialysis-associated peritonitis, prosthetic valve endocarditis, and meningitis

Polymicrobial disease: May occur

Diagnosis: Culture

Source treatment: Ceftazidime

Additional source agents: Ureidopenicillins, aminoglycosides, imipenem, meropenem, and ciprofloxacin

Treatment principle: Susceptibility-guided antimicrobial therapy

Device-associated infection: Consider appropriate source control

Key clinical pearl: Pseudomonas luteola, formerly Chryseomonas luteola, is a rare environmental Gram-negative bacillus notable for yellow pigmentation and opportunistic infections involving foreign material. The most useful clinical clue is an unusual Gram-negative bacteremia associated with a central venous catheter, although peritoneal dialysis peritonitis and prosthetic valve endocarditis are also characteristic reported presentations.

Infectious Disease and Microbiology – Pseudallescheria boydii

Overview

Pseudallescheria boydii is a filamentous fungus (mold) characterized by septate, hyaline hyphae. It has historically also been associated with the name Scedosporium apiospermum, although modern taxonomy distinguishes sexual and asexual forms within the Scedosporium/Pseudallescheria complex.

This environmental mold has a worldwide distribution and can cause both localized and invasive disease. Important manifestations include eumycetoma, pulmonary infection, brain abscess, osteomyelitis, sinusitis, ocular infection, endocarditis, fungal balls, and disseminated infection.

A particularly important clinical feature is that its invasive infections can closely resemble aspergillosis, but P. boydii/Scedosporium is characteristically poorly susceptible or resistant to amphotericin B.

Classification

Genus: Pseudallescheria

Species: Pseudallescheria boydii

Historical/related terminology:

Scedosporium apiospermum

Organism type: Filamentous fungus (mold)

Hyphae: Hyaline and septate

Microbiologic Characteristics

The characteristic morphology includes:

• Septate hyaline hyphae

• Filamentous mold growth

• Fungal aggregates or granules in mycetoma

• Hyaline septate hyphae in invasive hyalohyphomycosis

Because the hyphae may resemble those of Aspergillus, microbiologic identification is important.

High-Yield Microbiology Pattern

Hyaline mold

• ●

Septate hyphae

• ●

Aspergillus-like appearance

• ●

Poor amphotericin B activity

→ Think Pseudallescheria/Scedosporium

Incubation Period

The incubation period is:

Unknown

For mycetoma, infection is generally chronic and slowly progressive following environmental inoculation.

Epidemiology

P. boydii has a:

Worldwide distribution

The organism occurs environmentally in:

• Soil

• Polluted water

• Sewage-contaminated environments

• Organic material

Mycetoma is particularly common in:

Tropical and subtropical regions

Transmission

Localized infection may develop after:

Traumatic inoculation

of contaminated environmental material into:

Skin or subcutaneous tissue

This helps explain the frequent involvement of exposed areas such as:

Feet and hands

Mycetoma

One of the classic manifestations of P. boydii infection is:

MYCETOMA

Mycetoma is a chronic infection involving:

Skin + subcutaneous tissue

and may eventually extend into:

Bone

Classic Mycetoma Triad

The classic clinical triad is:

Tumefaction

• ●

Draining sinus tracts

• ●

Granules in the drainage

→ MYCETOMA

This is one of the most important exam patterns associated with the disease.

Tumefaction

Mycetoma produces a:

Slowly enlarging, tumor-like swelling

The lesion is usually chronic and may progress over a prolonged period.

Draining Sinus Tracts

As infection progresses, multiple:

Sinus tracts

may develop between the infected tissue and skin surface.

These tracts can discharge:

Pus containing characteristic granules

Granules

The granules contain aggregates of the causative organism.

In fungal mycetoma, microscopic examination may demonstrate:

Fungal hyphae within the granules

Recognition and culture of these structures can help identify the causative organism.

High-Yield Mycetoma Pattern

Tropical exposure

• ●

Chronic swelling of foot

• ●

Multiple draining sinuses

• ●

Granules in pus

→ Think MYCETOMA

Eumycetoma vs. Actinomycetoma

Mycetoma can be caused by either:

True fungi

or

Filamentous bacteria

Eumycetoma

Caused by:

Fungi

Examples include:

Pseudallescheria/Scedosporium

and other mycetoma-producing molds.

Actinomycetoma

Caused by filamentous bacteria such as:

Nocardia

and certain other aerobic actinomycetes.

Historically, Actinomyces has also appeared in discussions of mycetoma-like infections.

High-Yield Distinction

Eumycetoma

→ Fungal

Actinomycetoma

→ Bacterial

Both may produce:

Swelling + sinus tracts + granules

Sites of Mycetoma

The most characteristic sites are:

Feet

and

Hands

because these exposed areas are susceptible to traumatic environmental inoculation.

However, infection may occur on:

Any exposed body surface

Madura Foot

Mycetoma involving the foot is classically known as:

Madura foot

The clinical picture is:

Chronic foot swelling

• ●

Draining sinus tracts

• ●

Granules

Osteomyelitis

Chronic infection may extend from soft tissue into:

Underlying bone

resulting in:

Osteomyelitis

Bone involvement is an important complication of advanced mycetoma.

Hyalohyphomycosis

Outside the classic mycetoma syndrome, P. boydii can produce:

Hyalohyphomycosis

This refers to infection caused by molds that demonstrate:

Hyaline, septate hyphae in tissue

Aspergillus-Like Disease

An important diagnostic problem is that invasive P. boydii infection can resemble:

Aspergillus

in terms of:

• Clinical presentation

• Tissue appearance

• Septate hyphal morphology

Therefore:

Septate hyphae in tissue do not automatically mean Aspergillus.

Culture or other organism-specific identification is important.

High-Yield Diagnostic Trap

Septate hyaline hyphae

→ Do not automatically diagnose Aspergillus

If culture identifies:

Pseudallescheria/Scedosporium

the therapeutic implications are important because of differing antifungal susceptibility.

Pulmonary Infection

P. boydii may cause:

Pneumonia

particularly in susceptible patients.

Pulmonary disease can resemble:

Invasive pulmonary aspergillosis

and may occur in patients with underlying lung disease or impaired immunity.

Fungal Ball

The organism can colonize preexisting pulmonary cavities and form:

Fungal balls

This can closely resemble an:

Aspergilloma

High-Yield Pulmonary Pattern

Preexisting lung cavity

• ●

Fungal ball

• ●

Aspergillus-like septate hyphae

→ Consider Scedosporium/Pseudallescheria as well as Aspergillus

Brain Abscess

A particularly serious manifestation is:

Brain abscess

CNS disease can occur following dissemination or particular environmental exposures.

Neurologic manifestations depend on the location and extent of infection.

Near-Drowning Association

An especially important clinical association with Scedosporium apiospermum is:

Near-drowning in contaminated water

followed later by:

Central nervous system infection or brain abscess

This organism can be present in polluted water, making this exposure an important diagnostic clue.

High-Yield CNS Pattern

Near-drowning

• ●

Contaminated/polluted water exposure

• ●

Delayed brain abscess

→ Think Scedosporium apiospermum

Meningitis

The source also identifies:

Meningitis

as a possible manifestation.

CNS infection is serious and may be difficult to treat.

Eye Infections

Ocular manifestations may include:

• Keratitis

• Endophthalmitis

• Other invasive ocular infections

These may follow:

Trauma

or other direct inoculation events.

Sinusitis

P. boydii may cause:

Fungal sinusitis

The clinical and histopathologic appearance may resemble infection caused by other hyaline molds.

Endocarditis

Rarely, the organism may cause:

Endocarditis

This is a serious invasive manifestation and may require combined:

Antifungal therapy + surgical management

depending on the circumstances.

Disseminated Infection

In susceptible patients, P. boydii can cause:

Disseminated fungal infection

with involvement of multiple organs.

Risk is increased in patients with:

Significant immunosuppression

Diagnosis

Diagnosis is based on:

Culture

and

Identification of the organism in tissue biopsy specimens

For mycetoma, examination of:

Granules from draining sinus tracts

is particularly useful.

Examination of Granules

The granular material discharged from mycetoma lesions contains:

Aggregates of fungal elements

Microscopic examination can provide clues to the causative organism.

Culture is needed for more specific identification.

Histopathology

Tissue examination may demonstrate:

Septate hyaline hyphae

However, this appearance can resemble:

Aspergillus

Therefore, morphology alone may not reliably distinguish the two.

Culture

Culture is particularly important because:

Correct identification directly affects treatment

This is especially true when differentiating Scedosporium/Pseudallescheria from Aspergillus.

Treatment

The source emphasizes that treatment data are limited.

Historically, high-dose azoles such as:

• Itraconazole

• Miconazole

• Ketoconazole

were recommended.

For invasive Scedosporium apiospermum/Pseudallescheria boydii infection, voriconazole has become an especially important systemic antifungal option.

Amphotericin B Resistance

One of the most important treatment facts is:

AMPHOTERICIN B IS OFTEN INEFFECTIVE

against P. boydii/S. apiospermum.

This contrasts with many other serious invasive mold infections.

High-Yield Treatment Pattern

Aspergillus-like invasive mold infection

• ●

Septate hyaline hyphae

• ●

Poor response/resistance to amphotericin B

→ Think Scedosporium/Pseudallescheria

Surgical Management

Localized infection may require:

Surgical excision or debridement

This is particularly important for:

• Mycetoma

• Osteomyelitis

• Localized deep infection

• Abscesses

• Infected or necrotic tissue

Thus, management may require:

ANTIFUNGAL THERAPY

• ●

SURGICAL SOURCE CONTROL

Treatment of Mycetoma

Fungal mycetoma can be difficult to eradicate.

Management may require:

• Prolonged antifungal therapy

• Surgical debridement

• Excision of localized lesions

• Management of associated osteomyelitis

Extensive disease may be particularly challenging.

Pseudallescheria/Scedosporium vs. Aspergillus

Both can demonstrate:

Hyaline septate hyphae

and both may cause:

• Pneumonia

• Sinusitis

• CNS infection

• Fungal balls

• Disseminated disease

However:

Aspergillus

→ Classic acute-angle branching septate hyphae

→ Amphotericin B formulations can have activity against some species

Scedosporium apiospermum / Pseudallescheria boydii

→ Can closely mimic Aspergillus

→ Amphotericin B often has poor activity

→ Voriconazole is an important therapeutic agent

→ Notable association with CNS infection after near-drowning

Pseudallescheria vs. Mucorales

Pseudallescheria/Scedosporium

→ Septate, hyaline hyphae

Mucorales

→ Broad, ribbon-like, typically pauciseptate or aseptate hyphae

Thus, the hyphal morphology can help narrow the differential.

Pseudallescheria vs. Nocardia

Both may be associated with:

Mycetoma

However:

Pseudallescheria

→ Fungus

→ Hyaline septate hyphae

→ Eumycetoma

Nocardia

→ Filamentous bacterium

→ Gram-positive branching organism

→ Often weakly acid-fast

→ Actinomycetoma

Prevention

There is no specific vaccine.

General preventive measures include:

• Protecting feet and hands from penetrating environmental trauma

• Wearing footwear in endemic areas

• Cleaning contaminated wounds

• Appropriate management of traumatic injuries

• Avoiding unnecessary exposure of open wounds to contaminated soil or water

High-Yield Mycetoma Pattern

Tropical region

• ●

Chronic painless swelling of foot

• ●

Draining sinus tracts

• ●

Granules

→ Mycetoma

If caused by a hyaline mold such as Pseudallescheria:

→ Eumycetoma

High-Yield Invasive Pattern

Near-drowning in polluted water

• ●

Delayed CNS infection/brain abscess

• ●

Septate hyaline mold

→ Think Scedosporium apiospermum

Exam Essentials

Historical name: Pseudallescheria boydii

Related/currently used name: Scedosporium apiospermum complex

Type: Filamentous fungus (mold)

Hyphae: Hyaline and septate

Distribution: Worldwide

Mycetoma distribution: More common in tropical/subtropical regions

Classic localized disease: Eumycetoma

Classic mycetoma triad: Tumefaction + draining sinuses + granules

Classic site: Foot (Madura foot) and hands

Possible complication: Osteomyelitis

Other infections: Pneumonia, sinusitis, brain abscess, meningitis, ocular infection, endocarditis, fungal balls, and disseminated infection

Important exposure: Near-drowning → CNS infection/brain abscess

Histopathology: Septate hyaline hyphae

Major mimic: Aspergillus

Diagnosis: Culture + tissue biopsy, with examination of mycetoma granules when present

Major treatment clue: Amphotericin B often ineffective

Important systemic agent: Voriconazole

Source-listed azoles: High-dose itraconazole, miconazole, or ketoconazole

Source control: Surgical debridement/excision may be necessary

Key clinical pearl: Pseudallescheria boydii/Scedosporium apiospermum is a hyaline, septate mold that can cause eumycetoma or invasive disease closely resembling aspergillosis. Remember two particularly high-yield clues: chronic swelling with draining sinuses and granules indicates mycetoma, while delayed brain abscess after near-drowning in polluted water strongly suggests Scedosporium. Unlike many invasive molds, it often responds poorly to amphotericin B, making correct identification therapeutically important.

Infectious Disease and Microbiology – Providencia Species

Overview

Providencia species are Gram-negative bacilli within the order Enterobacterales. They are opportunistic pathogens particularly associated with healthcare-associated infections, especially complicated and catheter-associated urinary tract infections.

Important clinical manifestations include UTI, intra-abdominal infection, central venous catheter-related infection, and bacteremia. Providencia can develop substantial antimicrobial resistance, including extended-spectrum β-lactamase (ESBL) and other resistance mechanisms, making culture and susceptibility testing particularly important.

Classification

Genus: Providencia

Important species include:

• Providencia alcalifaciens

• Providencia rettgeri

• Providencia rustigianii

• Providencia stuartii

• Other species

Among these, P. stuartii and P. rettgeri are particularly important in healthcare-associated urinary infections.

Microbiologic Characteristics

Providencia species are generally:

• Gram-negative bacilli

• Facultatively anaerobic

• Members of Enterobacterales

• Motile

• Oxidase negative

• Phenylalanine deaminase positive

• Generally non-lactose fermenting

They are microbiologically related to:

Proteus

and

Morganella

High-Yield Microbiology Pattern

Gram-negative bacillus

• ●

Enterobacterales

• ●

Phenylalanine deaminase positive

• ●

Healthcare-associated UTI

→ Think Providencia

Incubation Period

A specific incubation period is usually not applicable because infection is commonly:

Endogenous or healthcare associated

Disease often develops in patients with underlying medical conditions or invasive devices.

Epidemiology

Providencia is particularly important as a:

Nosocomial pathogen

Risk factors include:

• Prolonged hospitalization

• Long-term care residence

• Chronic urinary catheterization

• Urinary tract abnormalities

• Repeated antimicrobial exposure

• Severe underlying disease

• Invasive medical devices

Providencia stuartii

Providencia stuartii is particularly associated with:

Long-term urinary catheterization

and

Healthcare-associated urinary tract infection

It has historically been an important pathogen in:

Long-term care facilities and chronically catheterized patients

High-Yield Clinical Association

Long-term care patient

• ●

Chronic urinary catheter

• ●

Gram-negative UTI

→ Consider Providencia stuartii

Providencia rettgeri

Providencia rettgeri is another clinically important species associated with:

• Urinary tract infections

• Healthcare-associated infections

• Bacteremia

Like other Providencia species, antimicrobial resistance may complicate treatment.

Urinary Tract Infection

The urinary tract is one of the most important sites of Providencia infection.

Clinical syndromes include:

• Catheter-associated UTI

• Complicated cystitis

• Pyelonephritis

• Urosepsis

The association with:

Indwelling urinary catheters

is particularly important.

Urease Production

Some clinically important Providencia species, particularly P. rettgeri, may produce:

UREASE

Urease breaks down urea and can contribute to:

Urinary alkalinization

and potentially:

Stone formation and catheter encrustation

This provides an important microbiologic connection with Proteus, although the classic urease–struvite association remains strongest with Proteus mirabilis.

Catheter-Associated UTI

Urinary catheters provide:

A surface for bacterial adherence and biofilm formation

and allow organisms to persist within the urinary tract.

Thus:

Chronic catheter

↓

Colonization/biofilm

↓

Persistent or recurrent bacteriuria

↓

Symptomatic UTI

↓

Possible ascending infection

↓

Bacteremia/urosepsis

High-Yield UTI Pattern

Hospitalized or long-term care patient

• ●

Chronic urinary catheter

• ●

Resistant Gram-negative bacillus

→ Think Providencia, particularly P. stuartii

Bacteremia

Providencia species can cause:

Bacteremia

The source may be:

• Urinary tract

• Central venous catheter

• Intra-abdominal infection

• Other invasive infection

Urinary-source bacteremia is particularly important in patients with complicated UTI.

Central Venous Catheter-Related Infection

The source also identifies:

Central venous catheter-related infection

as an important manifestation.

Management should include consideration of:

Catheter source control

in addition to appropriate antimicrobial therapy.

Intra-Abdominal Infection

Providencia may occasionally participate in:

Intra-abdominal infection

These infections can be:

Polymicrobial

and may require antimicrobial coverage beyond Providencia alone.

Abscess or other surgically correctable sources may require:

Drainage or operative source control

Nosocomial Infection

A major epidemiologic characteristic is the organism’s association with:

Healthcare-associated infection

This is clinically important because healthcare-associated isolates are more likely to have been exposed to antimicrobial selection pressure and may demonstrate:

Multidrug resistance

Diagnosis

The principal diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Urine

• Blood

• Central-line-associated blood cultures

• Abscess material

• Intra-abdominal specimens

Antimicrobial Susceptibility Testing

Susceptibility testing is particularly important because Providencia may possess or acquire multiple resistance mechanisms.

Therefore:

Identification alone is not sufficient

The isolate’s:

Antimicrobial susceptibility profile

should guide definitive treatment whenever possible.

Antimicrobial Resistance

Providencia species may demonstrate resistance involving:

• β-lactam antibiotics

• Fluoroquinolones

• Aminoglycosides

• Multiple other antimicrobial classes

Some strains can produce:

Extended-spectrum β-lactamases (ESBLs)

and more extensively resistant isolates may possess:

Carbapenemases

or other mechanisms.

ESBL

Extended-spectrum β-lactamases

can hydrolyze many:

Penicillins

and

Extended-spectrum cephalosporins

This is particularly important in healthcare-associated Gram-negative infections.

High-Yield Resistance Pattern

Nosocomial Providencia infection

• ●

Resistance to extended-spectrum cephalosporins

→ Consider ESBL or another β-lactam resistance mechanism

→ Use susceptibility results to guide therapy

Treatment

The source lists:

Meropenem

or

Imipenem

particularly when an ESBL-producing isolate is suspected.

It also lists:

Ciprofloxacin

as a treatment option.

Because susceptibility patterns vary considerably, definitive therapy should be based on:

Culture and antimicrobial susceptibility testing

rather than genus identification alone.

Additional Treatment Options

The source lists:

• Third-generation cephalosporins

• Aztreonam

• Ofloxacin

• Piperacillin–tazobactam

• Aminoglycosides

Whether any of these agents is appropriate depends on:

Documented susceptibility + infection severity + infection site

Important Aminoglycoside Consideration

An important microbiologic feature of Providencia is that susceptibility to individual aminoglycosides can be unpredictable.

In particular, some Providencia species have intrinsic resistance to certain aminoglycosides, so an aminoglycoside should not be assumed to be active without susceptibility information.

Source Control

Antimicrobial therapy alone may be insufficient when infected foreign material or an anatomic abnormality persists.

Important interventions may include:

• Removal or replacement of an unnecessary urinary catheter

• Management of urinary obstruction

• Evaluation of urinary stones

• Management of an infected central venous catheter

• Drainage of an intra-abdominal abscess

High-Yield Treatment Principle

Providencia infection

→ Obtain culture and susceptibility

• ●

Treat with an active antimicrobial

• ●

Correct the underlying catheter/device/anatomic source

Providencia vs. Proteus

Both belong to a related group of Enterobacterales and are:

Phenylalanine deaminase positive

Both may cause:

Urinary tract infection

However:

Proteus mirabilis

→ Famous for swarming motility

→ Strongly urease positive

→ Classic association with struvite/staghorn stones

Providencia

→ Particularly associated with nosocomial and catheter-associated UTI

→ P. stuartii is a classic long-term catheter organism

→ Antimicrobial resistance is an important concern

Providencia vs. Morganella

Providencia, Proteus, and Morganella form an important related group of Enterobacterales.

All may demonstrate:

Phenylalanine deaminase activity

and all can be opportunistic causes of:

Urinary tract and healthcare-associated infection

The specific organism is differentiated by biochemical testing and modern laboratory identification methods.

Providencia vs. E. coli

E. coli

→ Most common cause of community-acquired UTI

→ Common intestinal flora

→ Often lactose fermenting

Providencia

→ Less common overall

→ Particularly associated with healthcare settings

→ Important in chronically catheterized patients

→ Often non-lactose fermenting

→ Multidrug resistance can be prominent

Prevention

Prevention focuses primarily on reducing healthcare-associated infection.

Important measures include:

• Avoid unnecessary urinary catheterization

• Remove urinary catheters as soon as possible

• Maintain appropriate catheter care

• Use strict aseptic technique for central venous catheters

• Remove unnecessary vascular devices

• Follow infection-control precautions

• Use antimicrobials appropriately to reduce resistance selection

High-Yield Clinical Pattern

Long-term care or hospitalized patient

• ●

Chronic urinary catheter

• ●

Complicated UTI

• ●

Multidrug-resistant Gram-negative bacillus

→ Think Providencia, especially P. stuartii

Exam Essentials

Genus: Providencia

Important species: P. alcalifaciens, P. rettgeri, P. rustigianii, and P. stuartii

Type: Gram-negative bacillus

Order: Enterobacterales

Metabolism: Facultatively anaerobic

Oxidase: Negative

Motility: Generally motile

Phenylalanine deaminase: Positive

Related genera: Proteus and Morganella

Incubation: Usually not defined; often endogenous/healthcare associated

Major epidemiology: Nosocomial infection

Classic species: P. stuartii

Classic risk factor: Chronic urinary catheterization

Major infection: Complicated/catheter-associated UTI

Other infections: Intra-abdominal infection, central venous catheter infection, and bacteremia

Urease: Some species, particularly P. rettgeri, may be urease positive

Diagnosis: Culture

Resistance concern: Multidrug resistance and ESBL production; other resistance mechanisms may occur

Source ESBL treatment: Meropenem or imipenem

Source alternative: Ciprofloxacin if susceptible

Additional source agents: Third-generation cephalosporins, aztreonam, ofloxacin, piperacillin–tazobactam, and aminoglycosides

Management principle: Susceptibility-guided therapy + source control

Key clinical pearl: Providencia is a healthcare-associated Gram-negative bacillus that should be remembered particularly in chronically catheterized patients with complicated UTI. P. stuartii is the classic long-term catheter-associated species, while antimicrobial resistance—including ESBL and occasionally more extensive resistance mechanisms—makes culture and susceptibility-guided treatment essential.

Infectious Disease and Microbiology – Prototheca Species

Overview

Prototheca species are unusual unicellular, achlorophyllous algae that can cause a rare human infection known as protothecosis. Although they are algae, they lack chlorophyll and can grow on routine fungal media with a yeast-like appearance, which may lead to confusion with true fungi.

The most characteristic human manifestation is a chronic cutaneous or subcutaneous infection, often presenting as a relatively painless plaque or papulonodular lesion. Olecranon bursitis is another classic presentation. Disseminated disease, including bloodstream infection, peritonitis, and central nervous system infection, occurs mainly in immunocompromised patients.

Classification

Genus: Prototheca

Species listed in the source include:

• Prototheca stagnora

• Prototheca wickerhamii

• Prototheca zopfii

Organism type: Achlorophyllous alga

Disease: Protothecosis

Microbiologic Characteristics

Prototheca species are:

• Unicellular algae

• Achlorophyllous — they lack chlorophyll

• Capable of growing on fungal culture media

• Yeast-like in culture

• Reproduce by endosporulation

The lack of chlorophyll distinguishes Prototheca from typical photosynthetic algae.

High-Yield Microbiology Pattern

Unicellular alga

• ●

No chlorophyll

• ●

Yeast-like growth on fungal media

• ●

Endosporulation

→ Think Prototheca

Reproduction by Endosporulation

One of the most characteristic microbiologic features is:

Endosporulation

The parent cell, or:

Sporangium

develops multiple internal daughter cells known as:

Endospores

These are subsequently released and continue the reproductive cycle.

Morula-Like Appearance

On microscopic examination, the internal arrangement of endospores may produce a characteristic:

Morula-like appearance

or

“Soccer-ball” appearance

This can be a useful diagnostic clue in tissue or culture.

High-Yield Morphology Pattern

Large spherical cell

• ●

Multiple internal endospores

• ●

Morula/soccer-ball appearance

→ Prototheca

Epidemiology

Prototheca organisms are:

Ubiquitous in nature

They have been recovered particularly from:

• Soil

• Sewage

• Contaminated water

• Organic environmental material

Human protothecosis is:

Rare

but cases have been reported worldwide.

Transmission

Human infection is generally considered:

Environmental

rather than a person-to-person disease.

Cutaneous infection may follow environmental inoculation through:

Traumatized or damaged skin

Risk Factors

Although infection can occasionally occur in otherwise healthy individuals, more severe disease is associated with:

• Immunosuppression

• Malignancy

• Corticosteroid therapy

• Organ transplantation

• Other states of impaired host defense

Localized cutaneous infection and olecranon bursitis may occur without profound systemic immunosuppression.

Cutaneous Protothecosis

The best-described clinical syndrome is:

Skin and soft tissue infection

A characteristic lesion is:

Single + painless + plaque or papulonodular lesion

The lesion may subsequently:

Ulcerate

Clinical Appearance

Cutaneous disease may present with:

• Plaques

• Papules

• Nodules

• Papulonodular lesions

• Ulceration

• Chronic localized inflammation

The course is often:

Chronic and slowly progressive

rather than acutely toxic.

High-Yield Clinical Pattern

Environmental exposure

• ●

Chronic painless plaque/papulonodule

• ●

Occasional ulceration

• ●

Achlorophyllous algae in tissue

→ Think cutaneous protothecosis

Olecranon Bursitis

Another particularly characteristic manifestation is:

Olecranon bursitis

This involves inflammation and infection of the bursa overlying the:

Elbow

The association between Prototheca and chronic olecranon bursitis is sufficiently characteristic to be an important exam clue.

High-Yield Bursitis Pattern

Chronic olecranon bursitis

• ●

Environmental exposure or trauma

• ●

Unusual yeast-like organism

→ Consider Prototheca

Peritonitis

Rare cases of:

Peritonitis

have been reported in patients receiving:

Continuous ambulatory peritoneal dialysis (CAPD)

The peritoneal dialysis catheter provides an opportunity for an environmental organism to enter the peritoneal cavity.

High-Yield Dialysis Pattern

Peritoneal dialysis

• ●

Unusual persistent peritonitis

• ●

Yeast-like organism on fungal culture

→ Consider Prototheca

Meningitis

The source reports rare cases of:

Meningitis

particularly in patients with:

Advanced immunosuppression, including historically patients with AIDS.

Central nervous system disease is an uncommon manifestation of disseminated protothecosis.

Algaemia

Bloodstream infection with Prototheca has been described and may be called:

Algaemia

This manifestation is particularly associated with:

Immunocompromised hosts

and may indicate disseminated infection.

High-Yield Invasive Disease Pattern

Immunocompromised patient

• ●

Unusual yeast-like organism in blood

• ●

Organism actually identified as an achlorophyllous alga

→ Think Prototheca

Diagnosis

The principal diagnostic methods are:

Culture

and

Histopathologic examination of affected tissue

Because Prototheca grows on fungal media, it may initially resemble a yeast.

Culture

Prototheca species can grow on:

Routine fungal culture media

This characteristic contributes to their potential confusion with fungal organisms.

Species identification may require further microbiologic evaluation.

Histopathology

Biopsy of a cutaneous lesion may demonstrate:

Characteristic spherical organisms containing internal endospores

The presence of:

Multiple endospores within a sporangium

is an important morphologic clue.

Diagnostic Pattern

Chronic cutaneous lesion

• ●

Biopsy

• ●

Spherical sporangia containing multiple endospores

→ Prototheca

Differential Diagnosis

Because Prototheca can resemble yeast in culture or tissue, the differential may include:

• Fungal infection

• Chronic bacterial infection

• Other environmental organisms

• Noninfectious inflammatory lesions

Recognition of the characteristic:

Endosporulating sporangia

helps establish the diagnosis.

Prototheca vs. Yeast

Prototheca

→ Alga

→ Lacks chlorophyll

→ Yeast-like growth

→ Endosporulation

→ Sporangia containing multiple daughter cells

True yeast

→ Fungus

→ Commonly reproduces through budding or fission depending on species

→ Does not have the characteristic Prototheca endosporulating morphology

Prototheca vs. Chlorella

Both are algae, but:

Prototheca

→ Lacks chlorophyll

→ Nonphotosynthetic

→ Can cause human infection

Chlorella

→ Contains chlorophyll

→ Photosynthetic

Thus:

Prototheca = achlorophyllous alga

is the key distinction.

Treatment

The source lists:

Amphotericin B

as the principal treatment for protothecosis.

This is particularly important for:

Severe or disseminated disease

Additional Treatment

The source lists several azole antifungal agents:

• Itraconazole

• Ketoconazole

• Posaconazole

• Voriconazole

Despite Prototheca being an alga rather than a fungus, several conventional antifungal agents can have activity against it.

Treatment Considerations

Treatment should be individualized according to:

• Site of infection

• Severity

• Species

• Host immune status

• Susceptibility when available

Because protothecosis is rare, clinical experience is considerably more limited than for common fungal infections.

Surgical Management

Localized disease may sometimes benefit from:

Surgical excision or debridement

This can be particularly relevant for:

• Localized cutaneous lesions

• Olecranon bursitis

Thus, treatment may involve:

ANTIMICROBIAL THERAPY

• ●

SURGICAL SOURCE CONTROL

when appropriate.

Prevention

There is no specific vaccine or chemoprophylaxis.

General preventive measures include:

• Appropriate wound care

• Avoiding contamination of damaged skin

• Proper care of peritoneal dialysis equipment

• Appropriate catheter hygiene

• Infection-control practices in immunocompromised patients

High-Yield Clinical Pattern

Chronic painless skin plaque/nodule

or

Olecranon bursitis

• ●

Environmental exposure

• ●

Yeast-like growth on fungal media

• ●

Morula-like sporangia containing endospores

→ Think Prototheca

Exam Essentials

Genus: Prototheca

Important species: P. wickerhamii, P. zopfii, and P. stagnora

Organism: Unicellular achlorophyllous alga

Chlorophyll: Absent

Culture: Grows on fungal media with a yeast-like appearance

Reproduction: Endosporulation

Characteristic morphology: Sporangia containing multiple endospores

Classic appearance: Morula/soccer-ball pattern

Reservoir: Soil, sewage, water, and environmental organic material

Distribution: Worldwide

Disease: Protothecosis

Most characteristic infection: Cutaneous/soft tissue disease

Classic skin lesion: Painless plaque or papulonodular lesion, sometimes ulcerated

Classic focal association: Olecranon bursitis

Dialysis association: Peritonitis in peritoneal dialysis patients

Immunocompromised hosts: May develop disseminated infection, meningitis, or algaemia

Diagnosis: Culture + histopathology

Source treatment: Amphotericin B

Additional source treatments: Itraconazole, ketoconazole, posaconazole, or voriconazole

Localized disease: Surgical excision/debridement may sometimes be useful

Key clinical pearl: Prototheca is not a true fungus—it is an achlorophyllous alga that nevertheless grows with a yeast-like appearance on fungal media. The classic diagnostic combination is a chronic painless cutaneous plaque or olecranon bursitis with characteristic spherical sporangia containing multiple internal endospores, producing a morula or “soccer-ball” appearance.

Infectious Disease and Microbiology – Propionibacterium Species

Overview

Propionibacterium species are anaerobic Gram-positive bacilli that normally colonize human skin. The most clinically important species historically known as Propionibacterium acnes is now classified as Cutibacterium acnes.

These organisms are best known for their association with acne vulgaris and with indolent infections involving implanted or prosthetic material, particularly shoulder prostheses, cerebrospinal fluid shunts, prosthetic heart valves, and neurosurgical devices.

Classification

Historical genus: Propionibacterium

Important historical species: Propionibacterium acnes

Current terminology:

Propionibacterium acnes

→

Cutibacterium acnes

Organism type: Gram-positive bacillus

Taxonomy Update

The source lists:

P. ances

This appears to refer to:

P. acnes

The organism has subsequently been reclassified as:

Cutibacterium acnes

Therefore, the important modern name to remember is:

Cutibacterium acnes

Microbiologic Characteristics

C. acnes is generally:

• Gram-positive

• Bacillary or pleomorphic in morphology

• Anaerobic to aerotolerant

• Slow growing

• Non-spore-forming

• Part of normal skin flora

Its slow growth and normal presence on skin create an important diagnostic challenge:

Contaminant or true pathogen?

High-Yield Microbiology Pattern

Slow-growing Gram-positive bacillus

• ●

Normal skin flora

• ●

Prosthetic material

• ●

Indolent infection

→ Think Cutibacterium acnes

Incubation Period

The incubation period is:

Unknown

Most infections are:

Endogenous

and originate from the patient’s own skin microbiota.

This is especially important when organisms are introduced into deeper tissues during:

Surgery or implantation of prosthetic material

Epidemiology

Cutibacterium species are common components of:

Normal human skin flora

C. acnes particularly inhabits:

Sebaceous follicles

which helps explain its association with acne.

Pathogenesis

Two major clinical patterns should be remembered:

Sebaceous follicle colonization

→ Inflammation

→ Acne

and

Skin flora introduced during surgery

→ Adherence to implanted material

→ Biofilm formation

→ Chronic prosthetic/device infection

Biofilm Formation

An important characteristic of C. acnes is its ability to form:

Biofilms

on foreign material.

Biofilms allow organisms to:

• Adhere to prosthetic surfaces

• Persist despite host defenses

• Produce slowly progressive infection

• Become difficult to eradicate with antibiotics alone

This explains the organism’s strong association with:

Prosthetic and implanted-device infections

Acne Vulgaris

C. acnes is strongly associated with:

Acne vulgaris

The organism colonizes sebaceous follicles and participates in the inflammatory process associated with acne.

However, acne is multifactorial, involving more than bacterial colonization alone.

Important factors include:

• Follicular obstruction

• Sebum production

• Hormonal influences

• C. acnes

• Host inflammatory responses

High-Yield Acne Pattern

Sebaceous follicle

• ●

Comedones/inflammatory acne

• ●

Cutibacterium acnes

→ Acne vulgaris

Prosthetic Joint Infection

A major invasive manifestation is:

Prosthetic joint infection

C. acnes is especially important in:

Shoulder arthroplasty

and other orthopedic implants.

These infections may be relatively:

Indolent

rather than presenting with dramatic acute sepsis.

Shoulder Association

One of the strongest exam associations is:

Shoulder prosthesis

• ●

Slow, indolent postoperative infection

• ●

Slow-growing Gram-positive bacillus

→ Think Cutibacterium acnes

Clinical Presentation of Prosthetic Joint Infection

Possible manifestations include:

• Persistent joint pain

• Stiffness

• Reduced function

• Prosthetic loosening

• Subtle inflammatory findings

Fever and marked systemic illness may be absent.

This relatively subtle presentation can delay diagnosis.

CSF Shunt Infection

C. acnes can cause infections involving:

Cerebrospinal fluid shunts

The organism may adhere to the implanted device and produce:

Chronic or indolent shunt infection

Post-Neurosurgical Meningitis

The source also describes:

Meningitis following neurosurgical procedures

particularly in association with:

• Neurosurgical devices

• CSF shunts

• Other implanted material

Because the organism is slow growing, cultures may require appropriate incubation.

Endocarditis

C. acnes may cause:

Endocarditis

particularly when:

Prosthetic cardiac material

is present.

Prosthetic valve endocarditis may have a relatively indolent clinical course.

High-Yield Endocarditis Pattern

Prosthetic valve

• ●

Indolent endocarditis

• ●

Slow-growing skin-flora Gram-positive bacillus

→ Consider Cutibacterium acnes

Brain Abscess

The source also reports:

Brain abscess

as a possible manifestation, especially in clinical settings involving neurosurgery or implanted material.

Management may require:

Antimicrobial therapy

plus

Surgical drainage/source control

depending on the clinical situation.

Bacteremia

C. acnes can be recovered from:

Blood cultures

However, interpretation requires caution because the organism is:

Normal skin flora

and can contaminate blood cultures during collection.

Contaminant vs. True Pathogen

This is one of the most important clinical principles for C. acnes.

A positive culture may represent:

CONTAMINATION

or

TRUE INFECTION

Findings Supporting True Infection

True infection becomes more likely with:

• Multiple positive cultures

• Repeated isolation of the same organism

• Isolation from deep tissue surrounding a prosthesis

• Compatible clinical findings

• Prosthetic or implanted material

• Evidence of hardware loosening or infection

• Recovery from a normally sterile operative specimen

High-Yield Diagnostic Pattern

Cutibacterium in one blood culture

→ Could represent skin contamination

but

Repeated positive deep cultures + prosthetic material + compatible symptoms

→ Strongly consider true infection

Diagnosis

The principal diagnostic method is:

Culture

Because the organism grows relatively slowly and prefers anaerobic conditions, appropriate culture techniques are important.

Anaerobic Culture

Specimens should be obtained from:

• Deep tissue

• Prosthetic material

• Joint specimens

• CSF

• Blood

• Abscess material

Appropriate:

Anaerobic culture

and sufficient incubation time improve detection.

Diagnostic Challenge

C. acnes may be overlooked because:

It grows slowly

and

It is frequently assumed to be a contaminant

Therefore, clinical context is essential when determining whether a positive culture is significant.

Treatment of Acne

The source lists:

Tetracycline

or

Macrolide

therapy.

For acne, antimicrobial therapy is only one part of treatment, and modern management depends on acne severity and generally aims to limit unnecessary antibiotic exposure and resistance.

Treatment of Invasive Infection

Treatment of invasive C. acnes infection differs from routine acne therapy.

Management depends on:

• Infection site

• Presence of prosthetic material

• Antimicrobial susceptibility

• Severity

• Ability to remove or revise infected hardware

Because prosthetic infections involve biofilms, antimicrobial therapy alone may not always be sufficient.

Source Control

For device-associated disease, an important management principle is:

ANTIBIOTICS

• ●

DEVICE/SURGICAL SOURCE CONTROL

Depending on the infection, this may involve:

• Prosthesis revision

• Removal or replacement of an infected CSF shunt

• Debridement

• Drainage of an abscess

• Management of infected cardiac prosthetic material

Additional Antimicrobial Agents

The source lists:

• Trimethoprim–sulfamethoxazole

• Vancomycin

as additional treatment options.

Definitive treatment for serious invasive disease should be based on the:

Site of infection, susceptibility profile, and presence of prosthetic material.

Metronidazole Resistance

A particularly important microbiologic treatment clue is:

Cutibacterium acnes is resistant to metronidazole.

This is noteworthy because metronidazole is active against many anaerobic bacteria.

Therefore:

Anaerobic organism ≠ automatically susceptible to metronidazole

High-Yield Resistance Pattern

Anaerobic Gram-positive bacillus

• ●

Cutibacterium acnes

→ Metronidazole resistance

Prevention

Because many invasive infections are associated with surgical implantation of devices, prevention emphasizes:

Good antiseptic technique during surgery

This is particularly important because C. acnes normally resides within:

Sebaceous follicles of the skin

and can potentially contaminate the operative field.

Propionibacterium/Cutibacterium vs. Corynebacterium

Both may appear as:

Gram-positive bacilli

and both are associated with:

Skin flora

However:

Cutibacterium acnes

→ Anaerobic/aerotolerant

→ Slow growing

→ Acne

→ Strong association with prosthetic shoulder infection

Corynebacterium

→ Generally aerobic or facultative

→ Characteristic coryneform morphology

→ Includes both normal skin flora and important pathogens

Cutibacterium vs. Staphylococcus epidermidis

Both are important causes of:

Prosthetic-device infection

and both can form:

Biofilms

Cutibacterium acnes

→ Gram-positive bacillus

→ Slow-growing anaerobic/aerotolerant organism

→ Particularly associated with shoulder prostheses

Staphylococcus epidermidis

→ Gram-positive coccus

→ Coagulase-negative staphylococcus

→ Major cause of infections involving many types of indwelling devices

High-Yield Clinical Pattern

Shoulder arthroplasty

• ●

Chronic pain or prosthetic dysfunction

• ●

Minimal systemic inflammation

• ●

Slow-growing anaerobic Gram-positive bacillus

→ Think Cutibacterium acnes

Exam Essentials

Historical genus: Propionibacterium

Current important genus: Cutibacterium

Historical species: Propionibacterium acnes

Current name: Cutibacterium acnes

Type: Gram-positive bacillus

Growth: Slow-growing, anaerobic/aerotolerant

Normal habitat: Skin, particularly sebaceous follicles

Incubation: Unknown; invasive infections are usually endogenous

Classic superficial association: Acne vulgaris

Major invasive association: Prosthetic/device infection

Classic orthopedic association: Shoulder arthroplasty infection

Other device infections: CSF shunts and prosthetic cardiac material

Other diseases: Post-neurosurgical meningitis, brain abscess, bacteremia, endocarditis

Virulence feature: Biofilm formation

Diagnosis: Culture, often requiring anaerobic conditions and adequate incubation

Diagnostic challenge: Distinguishing contamination from true infection

Source acne treatment: Tetracycline or macrolide

Additional source agents: TMP-SMX and vancomycin

Important resistance: Metronidazole resistant

Device infection principle: Antimicrobial therapy + appropriate source control

Prevention: Careful surgical skin antisepsis and aseptic technique

Key clinical pearl: The organism historically called Propionibacterium acnes is now Cutibacterium acnes. Although it is common normal skin flora and may contaminate cultures, it is an important true pathogen in indolent prosthetic and device-associated infections—particularly shoulder arthroplasty infections. Its ability to form biofilms helps explain persistent hardware-associated disease, and a particularly useful antimicrobial clue is its resistance to metronidazole.